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A common maxim of protein biochemistry states, “structure is function.” This is 
generally just as true for an individual polypeptide chains as for multi-protein complexes. 
The advent of yeast tagged-protein libraries has allowed systematic screening of a 
protein’s local interaction partners as well as a roughly mapping its cellular location. 
Recently our group and others discovered hundreds proteins forming new structures in 
stationary phase yeast cells using the yeast GFP-tag library. That equates to well over a 
quarter of normally diffuse cytoplasmic proteins assembled into discrete structures that 
appear as foci or fibers, all of unknown function. This study provides evidence that many 
of these foci are formed by protein aggregation- that contrary the maxim, structure can be 
dysfunction. Furthermore, this study uses yeast to demonstrate the generality of 
cytoplasmic protein aggregation in response to a variety of stresses, provides evidence 
that increasing aggregation of particular cytoplasmic proteins correlates with aging even 
across organisms, and proposes a theoretical framework for how cellular energy levels 
affect protein aggregation propensity. 
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Chapter 1: Introduction 
 
My interest and involvement in the research described in this dissertation began 
following a talk by Gwendolyn Stovall were she described an astounding phenomenon 
discovered by Rammohan Narayanaswamy. He and fellow lab mates had been screening 
the yeast GFP-tagged strain library to track the intracellular location of proteins under 
various conditions. In a screen of this library grown to stationary phase he found 
hundreds of new cytoplasmic bodies. An astounding 30% of normally diffuse 
cytoplasmic proteins formed foci bodies or fibers, representing a massive restructuring of 
the yeast cytoplasm including much of central metabolism. However, far from being a 
unique occurrence, these structures are just the latest in a growing assortment of 
intracellular bodies formed by metabolic enzymes.  
 
In fact, observations of such bodies have increased markedly in recent years. The 
technological capacity to perform large-scale microscopy screens of protein localization 
has made possible cell biological studies that focus on particular cellular conditions. Such 
screens have been further abetted by the availability of extensive libraries of bacterial, 
yeast, and mammalian cells expressing proteins fused to reporters. In parallel, biologists 
and bioengineers have begun constructing novel multi-enzyme complexes in order to 
alter or improve metabolic capacity. Thus, the understanding of the cellular principles 
underlying the assembly of large protein bodies and their contribution to the dynamic 
regulation of metabolism is ripe for exploration and exploitation. 
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What follows is a brief background on intracellular protein bodies formed by 
metabolic enzymes. We discuss the current understanding of when and why such bodies 
form, and what their formation implies for the functionality—and dysfunctionality—of 
the enzymes that comprise them. We then describe several of the foundational 
experiments, as published by Narayanaswami et al. 2009 [1], as essential context for the 
remaining chapters. 
 
This chapter has, in part, been excised and reworked from a review by O’Connell 
et al. 2012 [107]. 
TYPES OF INTRACELLULAR BODIES 
 There are a wide variety of intracellular bodies, but they can be roughly classified 
based on their composition and structures. Bacteria for the most part (although exceptions 
exist) do not have membranous compartments, and thus their intracellular bodies tend to 
be almost exclusively proteinaceous, and to serve as sub-cellular compartments with 
specialized interiors optimized for their relevant biological roles. Originally called 
polyhedral bodies when discovered in electron micrographs of P. uncinatum in 1956, 
bacterial microcompartments are icosahedrons ~100-200 nm in diameter delimited by a 
3-4 nm thick protein shell [2]. 
 
 In eukaryotes the formation of membranous compartments is more the norm, and 
beyond mitochondria and chloroplasts a profusion of specialized intracellular metabolic 
compartments have been discovered in recent years. These compartments bear a 
particular relevance to studies of self-assembly of metabolic enzymes, as they frequently 
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exhibit a high level of enzyme self-organization. It can be argued that the crystalline or 
quasi-crystalline organization of at least some metabolic enzymes within intracellular 
membranous compartments is a direct result of their increased concentrations within 
these microbodies. 
 
Finally, beyond the microcompartments and microbodies discussed above, 
individual metabolic enzymes have been observed to form intracellular fibers and foci. 
Textbook cases for which the fiber is known to be the enzymatically active form include 
acetyl coA-carboxylase and β-glucosidase. Many additional examples of fiber-forming 
metabolic enzymes have been recently identified, but their functionality is as yet 
unestablished. 
 
Bacterial microcompartments 
The archetypal bacterial microcompartment, the carboxysome, earned its name 
and association with carbon fixation in 1973 when the CO2 fixing enzyme ribulose-1,5-
bisphosphate carboxylase/oxygenase (RuBisCO) copurified with polyhedral bodies from 
the aerobic sulfur bacterium H. neapolitanus [3]. Initial evidence (such as dispersal upon 
revival/re-feeding [4]) supported the idea that carboxysomes were storage bodies rather 
than the major sites of carbon fixation. However, studies over the next twenty years 
showed that the RuBisCO in carboxysomes was active, and that carboxysomes also 
contained carbonic anyhdrases to convert bicarbonate into CO2 [5], [6].  
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Crystal structures of carboxysome shell proteins model the wall as a single layer 
of interlocking hexagonal subunits with a pore in the center of each. The sheets of 
hexagonal subunits are joined at the vertexes by pentagonal subunits to complete the 
icosahedrons [7], [8]. The shell seems to provide selective permeability to metabolites, 
while blocking the diffusion of even smaller gas molecules by an unknown mechanism 
[9]. The co-localization of enzymes and substrates within the diffusion barrier of the 
carboxysome shell greatly increases the efficiency of carbon fixation, and carboxysomes 
are the main sites of CO2 capture in cyanobacteria. 
 
Searches for sequence homology to the major shell proteins have revealed that at 
least 189 bacterial species contain shell protein orthologs in gene clusters that potentially 
produce microcompartments [10]. Among these, microcompartments with functions other 
than CO2 capture have begun to be characterized. In E. coli and some S. enterica serovars 
orthologs of the carboxysome shell proteins were found in operons containing genes 
essential for growth on ethanolamine [11]. Acetylaldehyde, is a toxic and volatile 
intermediate in this pathway, and might otherwise rapidly diffuse away in the absence of 
the shell proteins. Thus, a portion of the ethanolamine degradation pathway occurs within 
an ethanolamine utilizing microcompartment (EUT) microcompartment [12]. A similar 1-
2 propanediol utilizing (PDU) microcompartment was found in an S. enterica serovar 
(Typhemurium) [13]. The PDU microcompartment may shield the cell from the toxic 
intermediate propionaldehyde [14], [15]. The discovery of an N-terminal targeting 
sequence for loading proteins into PDU microcompartments and the transgenic 
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expression of functional carboxysomes containing fusion proteins in E. coli mark the first 
steps toward rationally engineering bacterial microcompartments [16], [17].  
 
Aggregates within microbodies 
It is interesting that protein microcompartments are primarily found in bacteria, 
rather than eukaryotes, in the same way that it is interesting that bacteriophage primarily 
have protein coats, while their eukaryotic counterparts have membranous coats. It may be 
that as the complexity of a system scales, the opportunities for inadvertent protein mis-
aggregation also scale (a point we will touch on later), and that the less precise 
organization of lipids relative to proteins is a hedge against such aggregates. Conversely, 
as suggested above, enzyme compartmentalization may provide opportunities for 
increasing concentrations to the point where ordered aggregation is possible. Whatever 
the reason, eukaryotes frequently compartmentalize metabolic enzymes within 
membranes. We highlight three cases of ordered aggregates within peroxisomes as 
examples typical of bodies seen in other membrane bound compartments such as the 
mitochondria [18] and the chloroplast [19], [20].  
 
 Peroxisomes are eukaryotic microbodies bound by a single lipid membrane. 
These structures, typically 100 nm to 1 µm across, compartmentalize enzymes and 
substrates at high concentrations for particular metabolic pathways to improve the rates 
of catalysis or to shield the rest of the cell from the potential damaging effects of reactive 
intermediates.  
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 Most peroxisomes possess one or more enzymes for purine catabolism or salvage, 
usually xanthine oxidase and urate oxidase. These proteins are often clustered, even to 
the extent of forming amorphous and crystalline inclusions. Urate oxidase is a 
cuproprotein that normally forms homotetrameric rings, but in some mammalian 
peroxisomes these tetramers stack into fibers, which combine into crystalline cores [21]. 
These crystalline cores are a common feature of many types of peroxisomes, though their 
effects on the enzymatic activity are unknown.  
 
In plants, peroxisomes commonly specialize in ß-oxidation, as well as enzymes to 
remove hydrogen peroxide produced by the oxidases of ß-oxidation. Electron microscopy 
of plant peroxisomes reveals crystalline and amorphous inclusions, likely composed of 
catalase, a homotetrameric enzyme that degrades hydrogen peroxide [22]. Biochemical 
studies comparing crystalline catalase to diffuse catalase found that the crystalline 
catalase had up to 10-fold less specific activity but greater stability under UV, pH, and 
temperature stresses [23]. While there is a clear loss of function due to aggregation, the 
gain of structural stability in a highly oxidizing environment could be an example of 
adaptive change in catalytic potential mediated by forming larger aggregates.  
 
 Specialized types of peroxisome, called Woronin bodies, are found in filamentous 
fungi and staunch the flow of cytoplasm from hyphal wounds [24].The major and 
essential component of Woronin bodies is an aggregate of HEX protein oligomers 
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forming the eponymous hexameric crystalline cores. HEX proteins are most closely 
related in structure and sequence to eIF-5a, though the residues responsible for inter-
subunit contacts are different and the precise enzymatic function is unknown (Yuan et al. 
2003). Mutating residues at the oligomerization interface abolishes both the wound 
healing function and the classic polymerization phenotype, showing this to be an example 
of a functional aggregate [25].   
 
 In mammals the processed form of the ß-lactamase-like protein (LACTB) 
polymerizes into ordered filaments hundreds of micrometers in length in the 
intermembrane space of mitochondra [18]. It is unknown what role these fibers have 
within mitochondria, nor what drove the evolution of fiber formation from the non-fiber 
forming bacterial paralog. 
  
FIBERS AND FOCI 
 While microcompartments and membranous organelles are complex, highly 
structured organizing centers of metabolism, metabolic enzymes also self-assemble into a 
wide array of simpler intracellular bodies, among them fibers and foci. Many such bodies 
have been discovered— some are clearly functional; the functions of others have yet to 
be established. It can be argued that the probability of forming functional aggregates 
scales with the concentrations of the enzymes involved, and thus it may be unsurprising 
that a large number of these fibers and foci seem to be enzymes that support key 
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metabolic processes, such as carbon utilization, nitrogen fixation, and nucleotide 
biosynthesis.  
 
Fibers of metabolic proteins: carbon utilization 
Self-assembling fibers of a single enzyme are perhaps the simplest metabolic 
bodies observed in cells. The textbook example of a functional fiber is acetyl-CoA 
carboxylase; it was the first and remains the best characterized of all enzymatic fibers. 
Most mammals encode acetyl-CoA carboxylase as a single multi-domain protein, 
nominally a homodimer, but which can assemble into polymers with >50-fold greater 
activity [26], [27]. In mammals, there are two isoforms of the enzyme, one localized to 
the cytoplasm and the other to the mitochondria.  Both isoforms carry out the first and 
rate-limiting step of fatty acid biosynthesis by carboxylating acetyl-CoA to malonyl-
CoA. While polymerization is dependent on enzyme concentration, there are also a 
number of other mechanisms that shift the enzymes between inactive monomers and the 
active polymer form [28]. Phosphorylation / dephosphorylation will decrease / increase 
polymerization, respectively; allosteric binding of citrate induces polymerization, while 
excess product (malonyl-CoA) triggers depolymerization; polymerization can also be 
induced by MIG12 binding [29].  For the mitochondrial isoform MIG12 binding alone is 
sufficient to drive polymerization, and reduces the concentration of citrate needed for 
polymerization ~5-fold for the cytoplasmic isoform [29].  
Fibers of β-glucosidase were first reported in electron micrographs of oat plastids in 1965 
[30]. This enzyme is nominally a homohexamer that hydrolyzes β14 glucose bonds; it 
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also cleaves avencosides as an anti-fungal defense. Forty years later, structural studies 
revealed rings of hexamers stacked into fibers up to 2 µm in length [31], and biochemical 
analyses provided evidence that the fibers might be the active form of the enzyme: longer 
fibers were more active in hydrolyzing avencosides and more resistant to inhibitors than 
shorter fibers [31].  
 
Fibers of metabolic proteins: nitrogen utilization 
Several enzymes at the core of nitrogen metabolism also form fibers. Studies of E. 
coli glutamine synthetase (Class I), which catalyzes the ATP-driven addition of ammonia 
to glutamate, found that zinc progressively induces the dodecameric rings of the enzyme 
complex to aggregate into fibers [32]. Mammals have an eye-specific glutamine 
synthetase (Class I-like) that is catalytically inactive but essential for proper eye 
development [33], one of a number of chance adaptations of structured enzyme 
aggregates to serve as eye proteins, such as crystallins. In yeast, glutamine synthetase 
(Class II) is a decamer that forms foci in vivo under starvation conditions, although its 
ultrastructure remains to be determined [1]. When cells are starved of glutamine, they 
degrade glutamate to α-ketoglutarate and ammonia using the NAD-dependent glutamate 
dehydrogenase in mitochondria. In mammals, this enzyme normally forms 
homohexamers but at high concentrations associates into either highly ordered filaments 
or helical fiber bundles [34]. It is not clear what effect polymerization has on enzyme 
activity [35]; however, glutamate dehydrogenase has a host of allosteric regulators, 
including zinc, ADP, and GTP, and those that activate function also promote 
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polymerization and decrease thermal aggregation [36–40]. The reverse reaction—
glutamate synthesis—can be carried out either by highly related enzymes using NADPH 
as a cofactor, or by glutamate synthase, which carries out a transamination from  
glutamine to α-ketoglutarate forming two molecules of glutamate. In starved yeast, the 
GFP-tagged glutamate synthase forms fibers [41]; like glutamate dehydrogenase, the 
enzyme forms homohexamers, and the fibers observed by fluorescence microscopy may 
represent fibrillar bundles of the homohexamers.  
 
Fibers of metabolic proteins: nucleotide biosynthesis 
Cytidine triphosphate (CTP) synthase  
 
Recently, multiple groups have reported that CTP synthase forms filamentous and 
ring structures in vivo in the fly [41–43], bacteria [44], budding yeast [41], rat [41], and 
human cells [43], [45]. In the crescent-shaped bacterium C. crescentus, CTP synthase 
forms a single rod lining the inner curvature of the cell. In Drosophila, CTP synthase 
filaments, termed cytoophidia (meaning "cell snake"), exist in two forms, coined "micro-
cytoophidia" and "macro-cytoophidia," the latter being considerably thicker and longer 
than the former. In yeast, CTP synthase assembles into filaments as cells enter quiescence 
upon culture growth to stationary phase. In fact, yeast cells express two CTP synthase 
homologs, Ura7p and Ura8p, that co-localize within the same filaments, but not with 
other known filament-forming proteins [41]. 
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Initial data suggest that these fibers may be due to the self-association of CTP 
synthase, and do not require energy or special machinery (such as chaperones or 
scaffolds) for formation. Filaments are seen to form upon heterologous expression of C. 
crescentus CTP synthase in E. coli, and native E. coli CTP synthase forms filaments both 
in vivo and in vitro [44]. That said, a number of studies now implicate additional 
components in the fibers.  
 
While the filaments show distinct intracellular locations, these are apparently 
different in different organisms. In C. crescentus, CTP synthase filaments have been 
shown to co-localize to crescentin (CreS) along the inner curvature of the cell and 
apparently help regulate the crescent cell shape [44]. In rat neurons, CTP synthase 
filaments occurred in axons but not dendrites [41]. Fly micro-cytoophidia were found to 
associate with Golgi bodies and in some cases with microtubules (Liu 2010). In contrast, 
human and yeast CTP synthase filaments were not observed to co-localize with 
microtubules [41], [45], and human CTP synthase filaments were also not observed to co-
localize to Golgi bodies or centrosomes and were not enriched in actin or vimentin [45]. 
 
Compounds that modulate CTP synthase protein function modulate fiber 
formation. For example, CTP synthase inhibitors such as Acivicin and the glutamine 
analogs 6-diazo-5-oxo-L-norleucine (DON) and azaserine [43], [45] have dramatic 
effects on CTP synthase filaments. Interestingly, CTP synthase inhibitors produce 
different effects in different organisms: DON treatment disrupts CTP synthase filament 
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formation in C. crescentus, and also disrupts filaments of heterologously expressed C. 
crescentus CTP synthase in Schizosaccharomyces pombe or E. coli [44]. In contrast, 
DON and azaserine treatment promote filament formation in fly cells, and DON and 
Activin treatment induce filament formation in human cells [43], [45]. Notably, DON 
binding induces tertiary [46] and quaternary [47] structural changes in E. coli CTP 
synthase. As in the glutamine synthetase case mentioned above, such allosteric 
conformational changes also alter the conformational state of neighboring subunits 
coordinately [48], which is consistent with the hypothesis that differences in intersubunit 
amino acid contacts might be exposed or hidden by conformational changes. This would 
not only help to explain the evolution of fiber formation, but also how fiber formation is 
functionally related to regulatory logic. 
 
Filament formation can also vary broadly according to systemic conditions, 
including cell types, stages, and growth conditions. Ingerson-Mahar et al. reported that 
mCherry-CTP synthase filaments were generally shorter in newly formed stalked cells of 
C. crescentus, and then elongated with the progression of the cell cycle; subcellular 
localization was also dependent on cell cycle [44]. The opposite was observed in human 
cells, where expression of filaments occurred in all phases of the cell cycle in HEp-2 cells 
[45], and a similar ubiquity was found in HeLa cells [43]. However, in other human cells, 
the filaments varied by cell type and culture conditions. For example, undifferentiated, 
uninduced human embryonic stem cells contained CTP synthase rings and rods, but lost 
them when stimulated by retinoic acid to differentiate [45]. Similarly, filaments of the 
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yeast CTP synthase Ura7p are strongly induced by growth to saturation or glucose 
depletion, but disappear upon addition of fresh medium. Thus, CTP synthase fibers 
currently represent something of a quandary—while widely observed, they show mixed 
regulatory logic across organisms, and their enzymatic functionality has yet to be 
established.   
 
Inosine 5’-monophosphate dehydrogenase (IMPDH)  
In 2011, a study in human cells demonstrated that cytoplasmic filaments 
consisting of human CTP synthase also contained IMPDH [45]. IMPDH catalyzes the 
NAD-dependent oxidation of inosine monophosphate (IMP) to xanthosine 
monophosphate (XMP), the first and rate-limiting step for the synthesis of guanosine 
nucleotides. The predominant isotype, IMPDH type II, is highly expressed in neoplastic 
and differentiating cells, making it an inviting target for antiproliferation drugs, such as 
the immunosuppressive noncompetitive inhibitor mycophenolic acid (MPA) [49], [50]. 
MPA induced IMPDH rings and filaments in cultured human cells, reduced the enzyme’s 
specific activity in cell lysates, and induced purified IMPD homotetramers of ~15nm in 
diameter to form large, disordered aggregates in vitro [51]. Both MPA-induced rings and 
fibers in vivo and aggregation in vitro could be dispersed by the addition of GTP at 
physiological concentrations, with GTP addition restoring the activity of MPA-inhibited 
IMPDH in cell lysates [51]. These results are consistent with a hypothesis that MPA 
stabilizes inter-tetramer interactions, shifting the equilibrium between active IMPDH 
tetramers and inactive fibers to favor the inactive form. These results also beg the 
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question if cells might naturally form IMPDH fibers in order to store or regulate the 
enzyme in inactive form rather than destroying or recycling it. 
 
Purinosomes  
Although sampling may be biased by history, the enzymes of nucleotide 
metabolism appear to be particularly prone to form intracellular bodies. In particular, the 
existence of a multi-enzyme complex consisting of the all the members of the de novo 
purine biosynthesis pathway, termed the "purinosome," has been postulated for some 
time based on the accumulation of a variety of evidence from many experiments. The de 
novo purine biosynthesis pathway encompasses a ten-step enzymatic reaction converting 
phosphoribosyl pyrophosphate (PRPP) to inosine monophosphate (IMP). In higher 
eukaryotes such as mammals, de novo purine biosynthesis is carried out by 
phosphoribosyl pyrophosphate (PPAT), the trifunctional phosphoribosylglycinamide 
formyltransferase, phosphoribosylglycinamide synthetase, and 
phosphoribosylaminoimidazole synthetase (GART), phosphoribosylformylglycinamidine 
synthase (FGAMS), the bifunctional phosphoribosylaminoimidazole carboxylase and 
phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS), 
adenylosuccinate lyase (ADSL), and the bifunctional 5-aminoimidazole-4-carboxamide 
ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC). The de novo purine 
biosynthesis pathway is up-regulated when exogenous hypoxanthine is unavailable [52] 
[53]. 
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In higher eukaryotes these ten enzymes have fused into 6 polypeptide chains, 
three of which possess multiple active sites as listed above. Perhaps the most interesting 
of these is the trifunctional protein GART, which catalyzes the second, third, and fifth 
enzymatic steps in the pathway. Early hints that the purinosome might form included co-
immunoprecipitation of trifunctional GART and bifunctional PAICS from chicken liver 
[54] along with serine hydroxymethyl transferase and the trifunctional methylene 
tetrahydrofolate dehydrogenase (MTHFD1). These latter two enzymes form a cycle for 
the production of the labile 10-formyl tetrahydrafolate coenzymes required for steps 3 
and 9 of purine biosynthesis. Cross-linking studies in vitro found a physical interaction 
between GART and MTHFD1, and their interaction increases GART activity [55]. 
Fluorescence microscopy of transiently-expressed, fluorescently-tagged proteins showed 
colocalization between tetrahydroflolate synthase and both FGAMS and GART.  
 
In 2008, the Benkovic group reported the first direct observation of the 
purinosome in cells [56]. Fluorescent protein constructs of the six mammalian purine 
biosynthesis enzymes formed punctate intracellular foci when transiently over-expressed 
in HeLa cells in purine-depleted culture medium. FGAMS-GFP was shown to co-localize 
with the five other enzymes of the pathway, suggesting the assembly of de novo purine 
biosynthesis enzymes into purinosomes. FGAMS-GFP foci could be dissolved by 
exchanging purine-depleted for purine-rich medium, although the addition of the purine 
hypoxanthine to purine-depleted medium did not dissolve the foci. Intracellular bodies 
that included PPAT, GART, ADSL and ATIC were also detected via 
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immunofluorescence confocal microscopy of endogenous enzymes in a number of human 
cell types, including primary kerotinocytes. The bodies formed and dispersed when 
culturing cells in purine-depleted or purine rich medium, respectively [57]. 
 
Inhibitor studies have yielded some insights into the mechanism of purinosome 
formation. Addition of the microtubule-disrupting agent nocodazole reduced purinosome 
foci formation and decreased overall cellular purine synthesis [58], suggesting that the 
formation of these bodies may require cytoskeletal directed active transport. Casein 
kinase 2 (CK2) inhibitors 4,5,6,7-tetrabromo1H-benzimidazole and 2-dimethylamino-
4,5,6,7-tetrabromo-1H-bezimidazole induced foci formation by FGAMS-GFP, GART-
GFP, or PPAT-GFP, while the subsequent addition of a different CK2 inhibitor, 4,5,6,7-
tetrabromobenzotriazole, appeared to reverse or suppress foci formation. In addition, 
while CK2 inhibitors affected FGAMS-GFP, GART-GFP, and PPAT-GFP foci 
formation, similar effects were not seen on PAICS-GFP, ASL-GFP, and GFP-ATIC 
unless each was co-transfected with one of the former three proteins tagged with orange 
fluorescent protein (OFP)([58]). These results suggest a possible, but as yet unclear, role 
for CK2 in purinosome regulation.  One possibility is that phosphorylation by CK2 
disperses assemblies, as seen for acetyl CoA-carboxylase [59]. 
 
The study of the purinosome is also a case study in how the methods used to 
query intracellular bodies potentially influences outcomes. The visualized purinosome 
clusters have largely been observed by transient over-expression. In contrast, previous 
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efforts using cells stably transfected with purinosome constructs did not yield visible 
purinosome bodies [60]. Overexpression of proteins above their native levels has been 
shown to result in their aggregation [61–65], and the transiently overexpressed purine 
biosynthetic enzymes form intracellular bodies to extents that correspond to each 
enzyme's predicted aggregation propensity [66]. The resultant bodies are marked by 
ubiquitin and heat shock chaperones, suggesting that they may represent aggregated 
protein clusters [66]. 
 
The formation of functional purinosomes is not necessarily inconsistent with the 
observation of aggregated purine biosynthetic enzymes. Indeed, both may be true, 
depending on the cell state and method of observation. Purinosome bodies appear to be 
quite heterogeneous, as the penetrance of fluorescent body formation varied broadly for 
each individual enzyme, ranging from 5-77% of the cells [56]. A similar broad 
distribution was observed for CK2 inhibitor-mediated effects (ranging from 15-95% 
penetrance) [67]. Regulatory influences can also be interpreted in terms of either 
functional or non-functional aggregation (or both): while microtubules and CK2 could 
regulate purinosomes, they have also been implicated in general protein aggregation [68], 
[69]. Nocodozole inhibition of purinosome formation [70] is consistent with functional 
assembly requiring microtubules, but nocodozole treatment also inhibits inclusion body 
formation of aggregated huntingtin [68], [71]. Future studies will clearly be required to 
address the key questions of functionality of the purinosome bodies, ideally leading to 
purification and in vitro characterization, and to assess the relationships, if any, between 
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the intracellular bodies formed by overexpression of purine biosynthetic enzymes and the 
endogenous forms of those proteins.  
 
LARGE-SCALE SCREENS REVEAL MANY ADDITIONAL FOCI AND FIBERS  
 The frequency at which intracellular bodies have been found during the study of 
metabolism either indicates that metabolic enzymes are prone to aggregation, or perhaps 
that all enzymes are prone to aggregation and, to date, biochemists just happen to have 
largely studied metabolic enzymes. In fact, large-scale microscopy screens of protein 
localization dynamics have revealed tens to hundreds of additional enzymes that form 
intracellular bodies. Using cell microarrays, Narayanaswamy et al. surveyed large-scale 
trends in yeast (S. cereviseae) protein reorganization using a genome-wide green 
fluorescent protein (GFP) fusion library [72]. When ~800 yeast strains expressing 
normally cytosolic GFP-tagged proteins from their native locus in the genome were 
grown to stationary phase, 180 proteins involved in intermediary metabolism and stress 
response were observed to form punctate cytoplasmic foci. The formation of a number of 
these proteins was also confirmed by immunofluorescence and mass spectrometry of 
untagged proteins, with 33 proteins confirmed by both microscopy and mass 
spectrometry [1]. 
 
 A second screen of a portion of the S. cereviseae GFP library by Noree et al. 
found 27 additional foci structures (Noree et al. 2010). Of these, three were metabolic 
proteins that form fibers. One was a CTP synthase fiber (discussed above). The other two 
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fibers, composed of Psa1 and Glt1p, were entirely new. Psa1p is a GDP-mannose 
pyrophosphorylase essential for building the glycoprotieins of the cell wall and is highly 
conserved across eukaryotes. The other, Glt1p (also discussed above), was a NAD-
dependent glutamate synthase, which along with Gln1p forms one of the core ammonia 
incorporation pathways. It is currently unclear whether these fibers are functional and if 
so what role they might serve. 
 
 There have also been several systematic microscopy screens of protein 
localization performed in the fission yeast, Schizosaccharomyces pombe [73–76]. While 
these screens were not specifically searching for new structures, they still describe a 
number of proteins as existing as cytoplasmic 'dots' (e.g., CTP synthase and Ade4p, as 
was also seen in S. cerevisiae [1]) or in fibrous morphologies (e.g., Pil1p, an essential cell 
wall peptidoglycan synthetase).  
 
 A localization study of ~300 cytoplasmic proteins in Caulobacter crescentus by 
Werner and colleagues identified a number of proteins that showed non-diffuse 
localization [77]. Of these, they described 29 proteins' cellular distributions as foci, 129 
proteins as patchy/spotty, and 3 as filament-forming. Two of the filament-forming 
proteins are CTP synthase and an associated structural protein CreS. The other fiber is 
formed by UDP-N-acetylmuramate-alanine ligase. Similar to Psa1p, it is an essential 
enzyme for peptidoglycan synthesis. 
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 These large-scale screens clearly reveal a remarkably extensive assortment of 
intracellular bodies forming across diverse environmental conditions. It would appear 
that at least some of these bodies are metabolically inducible and form reversibly, 
strongly suggesting functionality. For example, the yeast purine biosynthetic enzyme 
Ade4-GFP formed foci in the absence of adenine, and cycling between punctate and 
diffuse phenotypes could be controlled by adenine subtraction and addition. Similarly, 
yeast glutamine synthetase (Gln1-GFP) foci cycled reversibly in the absence and 
presence of glucose [1]. Finally, there is good evidence for the yeast translation initiation 
regulatory complexes eIF2 and eIF2B existing as polymerized fibers during log phase 
growth [41]. As this is precisely when translation rates are the highest in yeast, it argues 
the fibers may be functional and regulated. However, as with the purinosome, caution 
must be used in interpreting whether the bodies form for functional roles, or whether 
regulated changes in concentration inadvertently lead to intracellular aggregates.  
 
Most large-scale localization studies use fusion proteins, and the properties of the 
tag can affect the solubility and interactions of the tagged protein. One recent study found 
that a commonly accepted body formed by Clp proteases was entirely dependent on 
certain fluorescent tags for formation. In the absence of a tag or using a GFP evolved for 
monomeric expression in E. coli, Clp proteases did not form the bodies. The authors 
propose that the fluorescent protein tags dimerize, causing homo-oligomeric complexes 
to assemble into an extended network and producing an intracellular body [78]. If this is a 
major cause of intracellular bodies, it predicts the set of foci forming proteins should be 
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strongly enriched for oligomers. Thus structures discovered by large-scale fluorescence 
localization screens need to be confirmed by orthogonal, preferably tag-free, methods to 
verify their biological relevance. 
 
WHAT’S GOING ON? THREE POTENTIAL ROLES FOR INTRACELLULAR BODIES  
The panoply of intracellular protein bodies also raises interesting questions 
regarding their evolution and maintenance within cells. We conclude by offering 
additional speculations on several particular aspects of how and why such bodies might 
evolve.  
 
Case studies such as CTP synthase and the purinosome raise many interesting 
questions regarding the functionality of intracellular bodies. It is thus useful to consider 
why metabolic enzymes might assemble into such large intracellular assemblies. In 
general, metabolic enzymes are notable for often forming complex quaternary structures, 
some larger (e.g. pyruvate dehydrogenase) than even the largest single proteins. It is 
possible that these massive intracellular assemblies provide functional advantages to the 
cell, such as catalytic efficiency or improved regulation. Alternatively, these structures 
might be depots for the storage of functional proteins or the disposal of dysfunctional 
ones. While we have seen that numerous metabolic enzymes clearly form functional and 
well-characterized meta-assemblies, it is not yet clear for many of the most recently 
discovered intracellular bodies whether they represent functional bodies, storage bodies, 
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or aggregates. Distinguishing these roles represents one of the major challenges for 
studying these structures. 
 
Catalytic efficiency and improved regulation 
Classically, enzymes have been thought to organize into multi-subunit assemblies 
in order to improve their functionality. Quaternary structures enable the channeling of 
substrates between active sites on individual subunits, thereby protecting labile 
intermediates from side reactions in the cell, or protecting the cell from toxic reaction 
intermediates. For example, the first intermediate substrate in de novo purine 
biosynthesis, 5-phosphoribosylamine, has a cellular half-life of 38 seconds, and 
channeling is essential for its subsequent coupling to glycine [79]. Also the addition of 
CO2 to aminoimidazole ribonucleotide to form 4-carboxy-5-aminoimidazole 
ribonucleotide occurs without the use of biotin or ATP. In plants, bacteria, and yeast this 
occurs through two enzymatic steps with N5-CAIR as an unstable intermediate substrate, 
perhaps driving the fusion of the enzymes responsible for these two steps in yeast and 
plants. Finally, the 5,10 formyl methylene tetrahydrofolate coenzyme used in steps 3 and 
9 is moderately labile, with a half-life of 30 min [55]. Such observations underpin the 
search for the purinosome, which would in principle localize the enzymes within 
sufficient proximity to prevent the diffusion of unstable intermediates or substrates. 
Similarly, the peroxisome shields cells from peroxide radicals generated by oxidases in 
fatty acid and purine catabolism. A related effect is seen in the formation of 
ethanolamine-utilizing microcompartments that shield cells during growth on 
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ethanolamine by localizing the production and degradation of toxic aldehydes within a 
protein shell.  
 
Channeling substrates between active sites in a quarternary structure or within a 
compartment can also greatly improve metabolic efficiency even when no side reactions 
are in play. For instance, carboxysomes prevent the diffusive loss of CO2 during carbon 
fixation and thereby allow unicellular organisms to achieve C4 plant-like efficiencies. In 
an even grander organization of metabolic machinery, the cellulosome anchors enzymes 
involved in cellulose production via elaborate, interlocking multidomain protein scaffolds 
on the cell surface.  
 
Finally, quarternary structure formation allows regulation by cooperative 
interactions and allosteric effectors. There are of course many such known examples of 
cooperativity in enzyme oligomers. Among these, the dodecameric glutamine synthetase 
from E. coli is one of the best understood. In addition to two covalent modification 
enzyme systems, glutamine synthetase has eight direct allosteric inhibitors that 
individually partially inhibit activity and together cooperatively inhibit activity [80]. The 
allosteric inhibitors bind active sites that are positioned at the interface between the 
subunits of the two hexameric rings, and in this way binding is transduced into structural 
changes that can be transmitted between enzymes in both rings. This mode of regulation 
effectively integrates information on the metabolic state of the cell with overall enzyme 
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activity [81], and such changes could in principle modulate the formation of glutamine 
synthase foci and fibers in vivo, although such an effect has yet to be shown. 
 
Storage depots 
It has also been hypothesized that proteins may assemble into macromolecular 
'depots' in which individual components can be transiently held and released. The 
advantage of such depots is that proteins need not be resynthesized but are instead 
retained for potential future use, especially in conditions where rapid redeployment may 
be required. For example, in the stationary (quiescent) phase, cells have a remarkable 
ability to weather extreme stress conditions and yet can rapidly re-enter the cell cycle 
[82]. Many changes accompany the transition into stationary phase. Stationary phase 
yeast cells, for example, exhibit decreased metabolic rates, increased size and density, 
and in general cease proliferating. The cell walls increase in thickness to provide osmo 
and thermotolerance, and the cells accumulate intracellular carbohydrates, including 
glycogen and trehalose, which may serve to help protect the cells against a variety of 
stresses [82]. Although rates of transcription and translation are dramatically decreased in 
quiescent cells as compared to exponentially growing cells [83], [84], the quiescent cells 
must remain able to rapidly restart growth when nutrients do become available. Quiescent 
cells have been shown to maintain available pools of important cellular components in 
forms that can be mobilized quickly, including cytoplasmic processing bodies (P-bodies) 
containing mRNAs that can be translated upon restarting growth [85], and ‘actin 
bodies’—localized accumulations of actin that can reassemble into actin fibers and 
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patches as necessary when cellular growth restarts [86]. Overall, quiescent cells appear to 
be rich with dynamic depots that are important for re-entry into the mitotic cell cycle. 
Such a trend is consistent with the tendency for many cellular proteins to be organized—
both spatially and functionally—in a manner consistent with the needs of the cell. 
 
Aggregation of dysfunctional and/or unfolded proteins 
In contrast to the above examples of intracellular bodies with active functional 
roles or storage of functional potential, a third major category of intracellular bodies is 
now well established—those composed of aggregated and possibly dysfunctional 
unfolded proteins. Such bodies often involve active cellular processes for collecting, 
sequestering, and disposing of the aggregates [87], but can also form when high levels of 
expression trigger self-association and aggregation [88]. Aggregated proteins are often 
sequestered, often via active transport along the cytoskeleton, to specific cellular sites, 
such as e.g. aggresomes [89], IPOD, and JUNQ [90]. 
 
The best characterized examples of protein aggregates and intracellular 
aggregation bodies include amyloid fibers and foci, and inclusion bodies. Amyloid fibers, 
in particular, are linked to a range of human diseases including Alzheimer’s, Parkinson's, 
and Huntington's [91], but also occur broadly across proteins and organisms [92], [93]. 
The toxicity of protein aggregates is generally attributed to not only the depletion of 
functional machinery [94], but also to the creation of pores inside cell membranes by 
small oligomers [95]. At the early stages of aggregation, small oligomers of amyloid 
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aggregates have structural similarities to pore-forming bacterial toxins and eukaryotic 
pore proteins [96], and their insertion into membranes leads to ion loss and cell death 
[97].  Both yeast and human prions constitute a continuous spectrum of aggregation with 
multiple morphologies [98], [99], and aggregated prion protein seeds can propagate 
readily to daughter cells [100].  
 
FOUNDATIONAL EXPERIMENTS 
S. cerevisiae GFP-strain library 
Researches in the lab of Erin O’Shea constructed the library with the goal of 
measuring the location of all the proteins inside a yeast cell. To create the library PCR 
products containing a short linker sequence followed by GFPS35T and a selectable 
marker gene were inserted at the C terminus of each protein-coding gene in S. cerevisiae 
through homologous recombination [72]. When expressed, each recombinant gene fusion 
produced a C-terminally GFP-tagged protein. Notably this method did not alter the 
transcriptional regulation of genes; GFP-tagged remained under the control of their native 
promotes, reducing the odds of expression based artifacts. They screened the library 
fluorescence microscopy imaging tagged strains in log phase growth and classified the 
location of GFP-tagged proteins for thousands of strains across 22 subcellular 
localization categories, achieving ~ 75% coverage of the yeast proteome. Of particular 
importance to the work here, they classified some 800 proteins as cytoplasmic. Which 
means a protein was distributed randomly throughout the cytoplasm in their screen. 
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Cell-chip screen of stationary phase yeast GFP-library strains 
Most microorganisms respond to starvation by arresting the cell cycle and enter a 
stationary phase, or G0 state. In a typical yeast culture the transition to stationary phase 
begins following the exhaustion of glucose [101]. Stationary phase cells differ from 
proliferating cells in a number of cellular physiological and metabolic processes. Budding 
ceases, translation rates drop 300-fold, the cell wall thickens, trehalose accumulates as 
glycogen is exhausted [82]. Global RNA expression profiling, shows an upregulation of 
environmental stress response pathways, with a surprising similarity to the expression 
profile observed in heat shocked cells [102]. Interestingly, passage through stationary 
phase ages cells, as measured by reduced replicative capacity upon resuming proliferative 
growth [103], suggesting an accumulation of damage inherent in the transition.  
  
Foundational experiments  
As stated, my thesis work is based directly on the finding of widespread foci 
formation of GFP-tagged cytoplasmic proteins in stationary phase yeast cells as described 
by Narayanaswami et al. 2009. In short, the authors grew yeast GFP strains originally 
characterized as cytoplasmically localized in YPD for 60h to reach stationary phase and 
assayed the intracellular distribution of the tagged proteins using the automated cell chip 
microscopy platform. The authors found potential localization changes in 256 proteins, 
which were manually rescreened under the same conditions. The manual rescreening 
verified 180 proteins showed a strong change in distribution from diffuse to foci or fiber 
morphology.  The dynamics of foci formation were characterized in detail to exemplify 
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the underlying diversity in regulation, and perhaps structure of morphological identical 
bodies. The two selected proteins were glutamine synthetase, Gln1-GFP, and 
pyrophosphate amino transferase, Ade4. These two showed differing induction and 
disappearance by metabolite depletion, translation inhibition, and protease inhibition. 
These two proteins were also extensively screened for co-localization with known 
cellular structures, but no colocalization was found, suggesting they are indeed novel 
bodies. However we can not rule out that some of the formed by the 178 untested GFP-
tagged proteins may yet represent re-localization to known intracellular bodies. 
We verified the reorganization of proteins into foci was not an artifact of the GFP-
tag by two methods. The first was differential partitioning of proteins between the soluble 
and the insoluble phase. We found that a strong correspondence between cytoplasmic 
proteins that transitioned and those that formed foci in stationary phase, suggesting the 
mass spec is an orthogonal method of measuring protein phase change by a systematic, 
untagged method. The second experiment was to track localization changes in stationary 
phase cells with an alternate tag, namely the tandem affinity purification (TAP) tag, and 
fluorescently labeled antibodies.  We found that TAP-tagged proteins showed the same 
foci formation in response to stationary phase and specific nutrient depletion as the GFP-
tagged versions. Other groups have since tested many of these bodies with other tags (e.g. 
HA-tagged fibers by Noree et al.  [41]), and in all cases found the assemblies to be 
independent of the C-terminal tag, suggesting intracellular body formation is an inherent 
property of many cytoplasmic proteins, in their untagged, native state. 
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Additionally, the results of two other experiments in the paper are revisited below 
as their full implications were not discussed in the paper. The first was the result of an 
experiment refeeding stationary phase cells containing Gln1-GFP foci with fresh media 
plus cycloheximide to block translation. If Gln1-GFP foci were storage bodies we might 
have observed a decrease in foci fluorescence intensity and an increase in cytoplasmic 
fluorescence intensity as Gln1-GFP proteins resumed their random distribution, as was 
seen in a similar experimental test of actin bodies [86]. Instead, we saw no dispersal. So 
either dispersal requires protein synthesis or Gln1-GFP foci are degraded in a translation 
dependent process. In support the second hypothesis is that one of the main effects of 
cycloheximide treatment is ubiquitin depletion, without which proteasome mediated 
degradation ceases [104].  Together with the results detailed in Chapter Two, this result 
argues Gln1-GFP foci are protein aggregates. 
 
The second is the result of an experiment in which log phase cells expressing 
Gln1-GFP were transferred to synthetic defined media lacking nitrogen. Nitrogen 
depletion strongly up-regulates Gln1 expression [105], and we saw a strong increase 
Gln1-GFP fluorescence indicating an increase in protein concentration. If Gln1-GFP foci 
are aggregates and protein aggregation were solely concentration dependent [106], then 
foci should have formed. Instead glucose depletion was necessary for Gln1-GFP foci 
formation, which suggests either a metabolite specific regulation or an energy component 
to in vivo protein aggregation – a topic we delve into further in Chapter Four. 
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Future Chapters 
 
Chapter Two provides evidence that the majority of foci discovered by 
Rammohan Narayanaswamy’s screen the GFP-library in stationary are not functional 
complexes, but dysfunctional protein aggregates. We also present a correlation between 
aging and increasing Gln1-GFP foci formation, to suggest aggregation may be a common 
feature of cytoplasmic proteins with implications for cellular senescence. 
 
In Chapter Three I measure global changes in the solubility of untagged proteins 
with age, as a systematic and unbiased verification of widespread decline in protein 
solubility in yeast over time. Many of the proteins showing this trend show a similar 
trend in aging worms suggesting the phenomenon may a conserved feature of aging. 
 
Chapter Four lays out additional evidence supporting widespread protein 
aggregation in large scale studies and how they provide support for an evolved balance 
between protein aggregation propensity and expression level. We extend this model to 
include the potential of cellular energy to shift this balance through mechanisms of 
proteostasis control. 
 
Finally, in Chapter Five, I discuss the possibility of conservation of widespread 
protein aggregation as a senescence factor during normal aging, speculate on general 
models for how complex quaternary structures form in the first place, and why they may 
be inevitable and propose a research direction to explore this new aspect of an old field.  
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Chapter 2: Widespread protein aggregation redefines cytoplasmic 
architecture in stress and aging 
INTRODUCTION 
A plethora of new cytoplasmic structures formed by large protein assemblies have 
recently been discovered in eukaryotic cells. In yeast alone, nearly 200 normally diffuse 
cytoplasmic proteins, including enzymes from nearly all main branches of metabolism, 
can be induced to form large intracellular bodies. These bodies appear within cells as foci 
or fibers by fluorescence microscopy, and form in response to specific nutrient depletions 
[1] or stresses [41][108]. The foci/fiber-forming tendencies for many of these proteins are 
in some cases conserved across large evolutionary distances. For instance, cytidine 
triphosphate synthase has been observed to form fibers in bacteria, yeast, fly, and human 
cells, though the function for the fiber form of the enzyme is not yet known in any of 
these organisms [41–43].  The cellular functions of these assemblies are thus an open 
question for the majority of these cases.   
 
 Where cytoplasmic protein bodies have been well-studied, three cellular roles are 
observed: enhanced metabolic processing, storage depots, or aggregation. Many central 
metabolic enzymes are known to form complexes, varying greatly in both size and 
diversity of composition. For example, the purinosome is thought to be composed of 
enzymes carrying out the ten steps of de novo purine biosynthesis, as well as cofactor-
producing enzymes [54]. Many of these proteins were reported to form a micrometer-
sized body to increase the flux through this pathway [54][56], although there is some 
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evidence that the foci in human cells may represent overexpression artifacts [66]. On the 
other end of the functional assembly spectrum are the fibers formed by acetyl-CoA 
carboxylase and beta-glucosidase, which are nearly homogeneous strands no more than 
20 nm wide. Both naturally occurring and artificially scaffolded metabolic pathways 
show improved flux [109] [110]. The evolutionary conservation of many of these 
structures, such as CTP synthase mentioned above, is often held up as evidence for a 
retained, undiscovered function. An alternate hypothesis is that the enzymatic structure 
optimal for catalysis is prone to nonfunctional or even dysfunctional oligomerization, and 
the conservation of function inherently preserves fiber formation [Ann Rev]. 
Additionally, some enzymes assemble into foci under conditions when their pathway’s 
end product is limiting and requires synthesis, such as adenine for Ade4p or pyruvate and 
ATP for Tdh1p [1].  
 
Alternatively, there are many proteins that assemble into storage bodies. Under 
cellular stress or yeast quiescence, filamentous actin dissembles its web-like network and 
contracts into discrete structures called actin bodies. Upon the resupply of nutrients, the 
actin bodies dissolve and actin returns to its normal fibrous form [86]. Similar conditions 
induce the formation of p-bodies and stress granules for the storage of mRNA along with 
a host of mRNA-binding proteins and components of the translational machinery 
[111][112][113]. In higher eukaryotes these mRNA bodies are formed by the aggregation 
of mRNA-binding proteins into unusual beta-amyloid aggregates, structures more 
typically associated with aggregation [114]. 
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In yeast, there are a number of bodies where aggregated proteins are shunted.  For 
refolding or degrading, proteins collect in the ‘juxtanuclear quality control’ compartment 
JUNQ [90], endoplasmic reticulum associated protein degradation (ERAD) machinery 
[90], or aggresome [89], all of which appear as paranuclear foci by fluorescence 
microscopy.  Permanently misfolded proteins are sequestered near cells’ exterior in 
distinct foci dubbed ‘insoluble protein deposits’ (IPODs) [90]. Mounting evidence 
suggests that many types of aggregation are highly specific for similar sequences. Thus, 
even within the above mentioned bodies, particular aggregated proteins may be 
associated largely with themselves and chaperones. Yeast foci often appear during the 
nutrient depletion phase of the post diauxic shift, which is the transition to stationary-
phase culture conditions and is stressful due to nutrient depletion and the accumulation of 
toxic metabolites [82]. Formation in response to stressful conditions is a hallmark of 
aggregation, supporting the hypothesis that many of these newly discovered protein 
assemblies are stress bodies. 
 
Here, we systematically screened the yeast proteome under various stresses to 
detect foci-forming proteins and to determine which of the three above-mentioned 
hypotheses best accounts for the role of these novel bodies. 
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RESULTS AND DISCUSSION 
 Testing for multienzyme assemblies of pathways 
Many of the proteins that were previously observed to form foci in a non-directed 
screen were also found to participate in known metabolic complexes in yeast or other 
organisms.  Amongst the complexes associated with foci were the trehalose synthase 
complex and the tRNA multisynthetase complex [115], [116].  There was also significant 
enrichment among foci-forming proteins for nitrogen metabolism and purine biosynthesis 
(as quantified by Gene Ontology annotations, Table S1) and for the previously observed 
purinosome.   
 
Based on these observations, we hypothesized that foci are composed of enzymes 
within a given pathway, potentially forming functional factories that improve metabolic 
efficiency.  However, if this were the case then it might also be expected that co-localized 
proteins would also show similar kinetics of foci formation.  Therefore, as a simple test 
of pathway assembly, we measured whether members of metabolic pathways show 
similar patterns  of induction of foci formation in response to specific or general nutrient 
depletion (Figure1A).  We assayed foci formation by 75 GFP-tagged proteins from 8 
major cytoplasmic processes selected from the Gene Ontology annotations enriched  in 
our previous screen of all cytoplasmic proteins [1] and pathways upregulated in 
stationary phase [102]. GFP-tagged strains were picked from the GFP-strain collection 
[117] and grown in each of 5 metabolically-limiting conditions. Fluorescence microscopy 
images were taken and scored for the presence or absence of foci as a binary score for a 
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total of 370 fluorescence microscopy screens.  We compiled these binary scores into a 
dissimilarity matrix and applied unsupervised hierarchical clustering using correlation 
distance at the measure. Surprisingly, hierarchical clustering did not group together 
members of a given cellular process which indicates there was little correlation in their 
foci induction patterns. 
 
Among the most correlated sets, as measured by co-clustering, were proteins from 
de novo purine biosynthesis and chaperone processes.  This observation nominally 
seemed to support the conservation of the hypothesized purinosome complex between 
yeast and human.  However, only Ade4p formed foci in response to end-product 
depletion (Figure 1B), a striking contrast to what has previously been observed in 
humans. In transiently transfected human cells, fluorescently tagged versions of all 6 
enzymes of the de novo purine biosynthesis pathway formed foci when grown in media 
dialyzed to remove purines [56].  Furthermore, the assemblies formed by various human 
enzymes of the de novo purine biosynthesis pathway co-localized with each other in 
transfected cells expressing pair-wise combinations of the fluorescently-tagged pathway 
members. We conducted a similar test for colocalization in yeast under general nutrient 
depletion by transfecting GFP-tagged strains with plasmid expressing Ade4-mCherry. Of 
all the pairs tested, Ade4-mCherry only co-localized with Ade4-GFP (Figure 1C), again 
contrasting the results seen in humans as evidence for a hypothesized purinosome. 
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 Figure 2-1. Disparate induction patterns argue that metabolic enzymes in the same 
pathway do not form foci in a coordinated fashion.  
A) A test of 75 GFP tagged proteins spanning 8 major cellular processes for their 
tendency to form in each of 5 metabolically limiting conditions found little concerted foci 
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induction B) The de novo purine biosysnthesis pathway illustrates to case; only the 
enzyme responsible for the first step, Ade4-GFP, forms foci in response to adenine 
depletion. C) Even under conditions where other members of the purine biosynthesis 
pathway formed foci, Ade4 did not colocalize with any other pathway members. The 
absence of coordinated induction, a hallmark of co-complex members, argues that most 
foci do not represent pathway specific multi-enzyme complexes.   
 
Heat shock causes similar sets of cytoplasmic proteins to become insoluble and form 
foci  
We next tested the possibility that the formation of foci was the result of a general 
collapse of proteostasis, leading to aggregation of normally soluble, diffuse proteins. If 
foci form by aggregation, then other stresses that lead to protein aggregation should 
induce foci formation as well. Heat shock, for instance, causes protein unfolding and 
triggers a number of response pathways to prevent, sequester, or degrade aggregated 
proteins. We systematically screened for changes in protein aggregation in response to 
heat shock by measuring the relative solubility of untagged cytoplasmic proteins in whole 
cell lysate by gross fractionation shotgun proteomics (Figure 2A). Mass spectrometry 
analysis of whole cell lysate was used to measure the solubility of roughly half of all 
cytoplasmic proteins (395 out of ~800).  
 
By comparing the relative solubility changes of cytoplasmic proteins between 
heat-shocked and normal log-phase cells, we explicitly controlled for any possible bias 
introduced by lysis that might induce insoluble partitioning. Following heat shock, 117 of 
these proteins became significantly more insoluble (Z-score > 1.96, Table S2) relative to 
the control. This set overlaps significantly with the set of proteins that formed foci in 
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stationary phase [1] (Figure 2B), suggesting that a subset of foci formed at stationary 
phase may also be formed by heat shock.  
 
Increased insolubility was previously observed to be strongly correlated with foci 
formation [1]. To test if increased insolubility due to heat shock was due to aggregation 
of proteins into foci, we repeated the heat shock experiment with GFP-tagged strains for 
four proteins from the intersection: Gln1-GFP, Gpm1-GFP, Ssa1-GFP, Ura7-GFP (the 
more highly expressed paralog of Ura8), and two proteins from outside the intersection 
(Yef3-GFP and Rpl24a-GFP). The four proteins that formed foci in stationary phase also 
formed foci following heat shock (Figure 2C), whereas the two proteins from outside the 
intersection did not form foci (data not shown). Interestingly, there was a difference in 
the population penetrance of the foci phenotype following heat shock compared to 
stationary phase, with fewer cells showing single, distinct foci and more cells showing a 
number of small foci, marked as indeterminate (Figure 2D). This difference is 
particularly stark for Gln1-GFP, where 90% of cells have a single clear protein aggregate 
in stationary phase compared to 25% in heat shock. This difference may reflect an 
impairment of cells’ ability to traffic small aggregates into a single large aggregate. 
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Figure 2-2. Foci forming proteins are significantly more likely to precipitated in vivo 
following heat shock suggesting they are assembling into stress bodies.  
A) Experimental design for measuring solubility changes of untagged proteins during 
heat shock as the relative partitioning between the soluble and insoluble phases compared 
to controls.  B) The set of proteins that become insoluble during heat shock significantly 
overlapped those that formed foci when GFP-tagged and those detected in our previous 
stationary phase mass spectrometry assay. Probability of overlaps was calculated as the 
iterated cumulative hypergeometric probability of all three sets. Proteins seen in all three 
sets are shown in the inset table. C) Proteins from the intersect of the GFP-tagged protein 
screen and those insoluble following heat shock were tested and found to form foci in 
response to heat shock. D) Quantifying change in GFP-tagged protein distribution shows 
a specific and distinct shift toward foci formation following heat shock. 
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Co-immunoprecipitation of foci forming proteins 
What then are foci composed of? We took a targeted approach to characterizing the 
components of a subset of foci by immunoprecipitating the protein assemblies and 
identifying the co-immunoprecipitating proteins. We began by purifying foci formed by 
the glutamine synthetase, Gln1-GFP. These Gln1-GFP foci survive cell lysis ostensibly 
intact, even apart from cellular debris (Figure 3A), and are strongly and specifically 
purified by antibodies targeting the GFP fusion (Figure 3B). We found that Gln1-GFP 
foci are composed almost exclusively of Gln1-GFP and the ubiquitous hsp90 chaperones 
Hsp82p and Hsc82p (Figure 3C, Spreadsheet S2 for full results). This differs markedly 
from co-purifying partners seen in log-phase cells in a TAP-tag screen, where Gln1 was 
associated with trehalose synthase (Tps1p) and the small heat shock protein Hsp42p. We 
constructed a dually fluorescent protein-tagged yeast strain in order to confirm the 
association and found that Gln1-GFP foci co-localized with Hsc82-TagRFP foci (data not 
shown).  
 
Hsp82-GFP 
While Hsp82-GFP foci do not detectably persist through cell lysis, those interactions 
that do persist should be a subset of the original composition. Among the set co-immuno-
precipitating proteins a significant number of the cytoplasmic proteins also form foci in 
GFP tagged strains (p<1.0E-3, Table S3), including a reciprocal enrichment for Gln1p.  
This suggests a role for the cytoplasmic Hsp82 in chaperoning a subset of foci-forming 
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proteins in subcellular structures, reminiscent of similar findings for IPOD and JUNQ 
forming proteins [90]. 
Ils1-GFP 
We see a different chaperone association for isoleucine tRNA synthetase, ILS1-GFP, 
which elutes primarily with the ribosome associated hsp70 chaperones, Ssb1p and Ssb2p 
(Figure 2C). The other members of the ribosome-associated complex (RAC), Ssz1p and 
Zuo1p, also co-purified (Spreadsheet S1).  The RAC chaperones nascent polypeptide 
chains during translation. The tRNA synthetases for methionine, alanine, valine, and 
threonine as well as the tRNA structural protein, Arc1p co-purified with ILS1-GFP. Of 
these, all but Mes1-GFP formed foci in stationary phase cells. Curiously we also see 
enrichment for several paralogs of the main structural protein of virus-like particles. This 
differs from the results of log phase protein interaction studies where no chaperone 
interactions have been reported. 
Cdc19-GFP 
Cdc19-GFP also shows enrichment for hsp70 class chaperones: Ssz1, Ssa2, and Ssb2 
(Figure 3G). Also detected, where Hsp82 and Hsp104 though with less significant Z-
scores and fold enrichments. More significantly enrichments were measured for several 
translation associated proteins, as well as fellow members of glycolysis, most strongly for 
Pdh1p. Among these is Acs1 whose paralog, Acs2, was detected as an interaction partner 
in log phase protein interaction screen [118]. 
Ade4-GFP 
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The first step in the de novo purine biosynthesis pathway is catalyzed by Ade4p. In 
stationary phase cells Ade4-GFP co-purifies most strongly with a number of Golgi 
proteins, notably the alpha-1,6 mannosyltransferase complex, (Hoc1p, Anp1p, Mnn9p, 
Mnn10p, and Mnn11p)(Figure 3H). There was also enrichment for Udf1p and Cdc48p 
which deliver poly-ubiquinated proteins to the proteasome for degradation. A weak, but 
significant enrichment was measured for only one other member of the de novo purine 
biosynthesis pathway, namely Ade5,7p. Perhaps the minor subset of diffusely distributed 
Ade4p possess such interactions, however no colocalization was detected between Ade-
mCherry foci and Ade5,7-GFP foci (Figure 1C).  
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Figure 2-3. Immunopurification reveals diversity of foci composition, with a 
common theme of protein quality control.  
A) Gln1-GFP, while diffuse in log phase cells, localized predominantly into foci in 
stationary phase cells-foci which persisted in lysate and B) could be selectively purified 
by immunoprecipitation with goat anti-GFP antibodies and visualized by western blot 
with mouse anti-GFP antibodies. Proteins that coimmunopurified with various GFP-
tagged, foci-forming proteins were assayed by shotgun mass spectrometry. Identified 
proteins are arranged by significance of enrichment relative to the untagged control 
strain, BY4741, on the X-axis and the fold change of enrichment on the Y-axis for each 
bait protein tested. C) Immunoprecipitation of Gln1-GFP from stationary phase cells co-
immunoprecipitated the cytoplasmic hsp90 class heat shock proteins Hsp82 and Hsc82. 
D) Conversely, among the many interaction partners identified with Hsp82-GFP, Gln1 
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was reciprocally enriched. E) Of the 50 cytoplasmic proteins that copurify with Hsp82-
GFP a significant number (21, shown in blue in D) have been observed to form foci 
(p<0.001, Table S3) suggesting a subset of foci forming proteins are hsp90 clients in their 
foci forming state. F) Ils1-GFP also copurified with chaperones, but in with the hsp70 
class chaperones Ssb1 and Ssb2. There were also several other tRNA synthetases that co-
purified. G) Cdc19-GFP also copurified with hsp70 class chaperones as fellow members 
of glycolysis, notably Pdh1p. H) Ade4-GFP showed no significant chaperone 
interactions; instead interactions with Golgi to ER transport proteins were enriched, as 
well as autophagy proteins, Atg9p, Atg23 and Vac8, as well as ERAD components, 
UFD1 and CDC48. 
 
Arsenic induced insolubility recapitulates stationary phase induced insolubility  
Arsenic is thought to be toxic to cells both by damaging cytoplasmic proteins 
directly by reacting with reduced thiol groups [119] destabilizing and unfolding them, 
and by inhibiting chaperones that would help fold unfolded nascent chains and 
misfolding proteins [120]. Jackobson et al. reported widespread protein aggregation in 
yeast after treating cells with 1.5mM arsenite, As(III), for one hour as measured by 
shotgun mass spectrometry of fractionated cell lysate. Overall, 143 proteins showed a 
significant shift toward the insoluble fraction following arsenic treatment, 59 of which 
were cytoplasmic proteins (Table S4).  Comparing this set of 59 proteins to the set of 114 
proteins that were more insoluble in stationary phase[1], we find a significant overlap of 
22 proteins (Hypergeometric test, p < 2.8E-6, Figure 4A). Both conditions also induce 
foci formation. For instance the AAA chaperone Hsp104-GFP and stress granule marker 
Pab1-GFP both form foci in each condition (Figure 4B) [1] [120]. Similar to the heat 
shock experiment, these results suggests a many cytoplasmic proteins aggregate in 
response to diverse types of stress, and a common subset of chaperones respond to 
sequester the aggregates, including forming foci.  
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Figure 2-4. A similar set of cytoplasmic proteins aggregate and form foci in response 
to arsenic and stationary phase nutrient depletion.  
A) A Venn diagram illustrating the statistically significant overlap between proteins that 
become more insoluble following arsenic treatment of yeast cells and proteins more 
insoluble in stationary phase cells. B) Log phase cells stressed with 0.1mM arsenic[120] 
and stationary phase cells both harbor aggregate bodies, which appear as foci in GFP-
tagged strains, such as Hsp104-GFP shown here.  
 
Gln1-GFP foci formation correlates with aging 
Many mechanisms cells use to handle and clear protein aggregates decline with 
age across model systems. Chaperone expression decreases [121], proteasome activity 
diminishes [122], and chaperone mediated autophagy slows with increasing cellular and 
organismal age [123]. This potentially contributes to the accumulation of aggregation in 
several age related diseases, such as plaques in Alzheimer’s disease [124], and aggregates 
of any other protein as well. Recent work in worms suggests widespread aggregation 
occurs normally in the course of aging [125]. If the foci are the result of general 
aggregation, we speculated their incidence should be correlated with increasing cell age. 
Two easily noticeable phenotypes for aging in yeast are expansion of cell volume [126], 
and the accumulation of bud scars [127],[128]. We used Gln1-GFP foci formation as a 
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model foci forming protein due to its high signal to noise ratio. Cell size and foci per cell, 
as measured by fluorescence microscopy, revealed a correlation between the frequency of 
Gln1-GFP foci formation and cell size (Figure 5A R2=0.78). Repeating the experiment 
by, fluorescence activated cell sorting (FACS) of cells by size again found cells with foci 
were significantly larger than cells without foci (Figure 5B, p< 0.0001). Similarly, old 
cells were enriched by FAC sorting cells by fluorescence intensity for bud scar marker, 
Calcofluor white. Cells with more bud scars were more likely to contain more foci, 
though the correlation was not linear, with a large jump in the mean number of bud scars 
between cells with no bud scars and cells with 1 bud scar (Figure 5C). The difference was 
even more striking when we narrow the analysis strictly to pairs of mother and daughter 
cells. Mother cells were significantly more likely to have Gln1-GFP foci than the 
daughter cells (Figure 5D,t-test p< 3.2-10) suggesting retention of foci by mother cells, a 
hallmark of aging factors in yeast.   
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Figure 2-5. Gln1-GFP foci formation correlates with markers of cellular age.  
A) Increasing cell size is a marker for age, and positively correlates with likelihood to 
show Gln1-GFP foci as measured by a manual screen (R2=0.78). B)  Gln1-GFP foci 
formation is more likely in larger cells as assayed by Fluorescence Activated Cell Sorting 
(FACS) cells by size and manually scoring foci. C) Similarly, FAC sorting cells by bud 
scar and manually counting foci per cell found cells with more bud scars were more 
likely to contain more foci. D) Reproductively older mother cells, as measured by bud-
scars, are more likely to have Gln1-GFP foci and multiple foci than reproductively naive 
daughters. 
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Rapamycin treatment suppresses Gln1-GFP foci formation 
Rapamycin is one of the few chemical interventions that increases lifespan of 
cells in culture across a wide range of eukaryotes, including yeast [129], worm [130], fly 
[131], mouse [132], and human [133]. Within cells, rapamycin binds to FK-binding 
protein 12, which then binds to and inhibits the highly conserved TOR Compex1 
(TORC1)[134]. TORC1 activates metabolism to fuel the cell cycle in proportion to 
available metabolites. When TORC1 is inhibited cells behave as if starved, arresting 
division in G0 [135] and releasing the repression of autophagy and the Msn2/Msn4-
mediated stress response pathways [136][137]. Rapamycin also decreases translation 
initiation and ribosome biogenesis, collectively decreasing the steady-state protein 
concentration inside cells [138]. Together, these effects reduce the protein aggregation 
load within a cell. Recently, rapamycin derivatives have even shown promise in treating 
diseases caused by aggregation, including progeria [133]. 
 
Because foci formation increases with aging, we hypothesized that rapamycin 
treatment, which decelerates aging and activates stress response pathways, should prevent 
foci formation. To test this hypothesis, we grew Gln1-GFP tagged yeast in increasing 
concentrations of the drug for 24 hours. Using imaging flow cytometry, we developed a 
protocol to automatically image and score foci within tens of thousands of cells per 
sample, in this manner achieving more accurate and unbiased statistics (Figure 6A). We 
found a clear dose-dependent reduction in Gln1-GFP foci in response to rapamycin 
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treatment (Figure 6B). Together, these results show that Gln1-GFP foci bear many of the 
traits of age-dependent aggregation. 
 
 
Figure 2-6. Rapamycin treatment prevents Gln1-GFP foci formation.  
A) The proportions of cells exhibiting visible Gln1-GFP foci were measured in an 
unbiased fashion by automatically imaging cells at high-throughput using imaging flow 
cytometry (ImageStream), and identifying and quantifying the relevant cell 
subpopulations as shown. B) Using this strategy, we observed that rapamycin treatment 
induced a dose-dependent reduction in the proportions of cells with Gln1-GFP foci 
formation across a concentration range of 1 to 200 nM.  
 
 
Most foci are not multi-enzyme factories 
Massive rearrangements of cytoplasmic structures occur in response to a variety 
of stresses. Notably, many proteins condense into concentrated pockets [139][113][1], 
effectively decreasing the concentration of normally diffuse proteins.  These changes 
alter translation, chaperone capacity, and likely metabolism in the cytoplasm, both within 
and outside the foci. There are many examples of metabolically active, heterogeneous 
protein megacomplexes whose formation is regulated in response to nutrient availability. 
Notable examples include carboxysomes [140], cellulosomes [141], and perhaps 
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purinosomes in humans [67]. Most of the observed yeast protein foci are inconsistent 
with such structures; we observed that proteins within the same pathway do not generally 
form foci under the same induction conditions. If proteins do not form assemblies at the 
same time, it precludes the possibility of their co-assembly into the same structures. In 
particular we concluded that purine biosynthesis enzymes in yeast do not collectively 
form foci representing purinosomes. More generally, foci do not appear consistent with 
multi-enzyme factories catalyzing consecutive metabolic reactions. 
 
The two classes of proteins that showed the greatest coordinated induction in this 
study were chaperones and de novo purine biosynthesis enzymes. For the latter, we did 
not observe colocalization of the enzyme carrying out the first step of the pathway, 
Ade4p, with other enzymes in the pathway (and, as noted previously, observation of 
colocalization in human cells depend strongly on overexpression [66], raising the 
possibility that they represent aggregates). Similarly, pull-downs of Ade4-GFP 
immunoprecipitated one other members of the purine biosynthesis pathway, Ade5,7, and 
the association was weaker (<1/20 of the abundance of Ade4-GFP) than other 
presumably non-specifically associating proteins. Such weak associations may either 
represent a highly unstable complex, or more likely—given the lack of fluorescence co-
localization—associations with the minor population of diffuse Ade4-GFP rather than the 
major population of foci-associated Ade4-GFP. Studies of physical associations in log-
phase cells have not found any association between the members of the purine 
biosynthesis pathway and Ade4p, other than oligomerization of Ade4p itself. Rather than 
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forming a purinosome, the data may suggest that Ade4p either forms large homo-
oligomers, as for acetyl-CoA carboxylase, or an aggregate. Thus, in general, foci do not 
appear to be consistent with the organization of more extensive metabolic pathways for 
the purposes of substrate channeling or enhanced metabolic efficiency.  
 
Many foci are novel stress bodies 
While proteins, particularly RNA binding proteins and chaperones, are known to 
form stress bodies in response to nutrient depletion or heat shock, the scope of additional 
proteins from diverse pathways added to the list in this study is unprecedented. Having 
ruled out the hypothesis that the foci we see represent a vast array of pathway spanning 
multi-enzyme complexes, the next logical hypothesis the data support is novel stress 
bodies. Many proteins from central metabolism, translation, and chaperones collapsed 
into insoluble bodies in response to a variety of stresses. These bodies could either be 
storage bodies, like actin bodies, or general aggregation like aggresomes. However, the 
line between these alternatives blurred in the wake of recent work showing RNA granules 
are formed by β-amyloid aggregation of low complexity regions within partially unfolded 
RNA-binding proteins[114]. The granules appear as foci within cells and are insoluble 
upon lysis.  However, the proteins retain their RNA-binding capacity, and unlike amyloid 
aggregates associated with prions or neural plaques, are highly dynamic and specific only 
the type rather than the sequence of amino acid side chains.  
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General, widespread aggregation of cytoplasmic proteins 
There are several lines of evidence that many of the foci are aggregates. We 
previously found foci forming proteins were computationally predicted to have a higher 
propensity to aggregate than non-foci forming proteins using the TANGO 
algorithm[142]. Stressing cells with heat shock or arsenic, which are known to cause 
aggregation, drive to the insoluble phase many of the same proteins that form foci. Indeed 
insoluble shifts were predictive of foci formation. Of the foci forming proteins we studied 
in detail, Gln1 seems the most likely to be forming aggregates; it forms foci in response 
to nearly every stress tested, co-immunoprecipitates with chaperones, and its percent 
penetrance in the population correlates increasing aging phenotypes. 
 
Further, Gln1-GFP foci are unlikely to be a storage body as foci formed by 
nutrient depletion did not disperse when new media with cycloheximide was added [1]. 
So recovery of diffuse Gln1-GFP requires new protein synthesis. One of the main effects 
of cycloheximide treatment is the depletion of ubiquitin [104]; so perhaps the required 
protein synthesis required for Gln1-GFP foci disappearance is additional ubiquitin to 
target it to the protein quality control machinery. We speculate that the set of proteins 
that, like Gln1, shifted to the insoluble phase in response various stresses are forming foci 
composed of aggregates.  Top candidates would be foci forming proteins that show novel 
chaperone associations in stationary phase or under stress, such as the foci forming 
proteins that co-immunoprecipitated with Hsp82-GFP. 
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Given the fitness cost of clearing aggregates formed by the expression of one a 
non-functional gene is above 3.2% decrease in growth rate [143], why do cells allow up 
to 20% of cytoplasmic proteins to crash out at a common, even routine stress such as 
nutrient depletion? One possibility is many evolutionarily ancient proteins are trapped in 
a local minimum in sequence space with limited options to explore while maintaining 
essential functions proteins. These proteins may be expressed near the limits of solubility 
or beyond in order to cope with the stress and cells accept the costs of cleaning up 
aggregated proteins to achieve higher enzyme concentrations. A second alternative is 
aggregation serves a function for rapidly changing protein activity, e.g. RNA granule 
formation mentioned above.  
CONCLUSION 
In summary, our findings suggest widespread foci formation represents extensive 
protein aggregation that dramatically alters the organization of the yeast cytoplasm under 
stress. Our results imply many of the assumptions about cytoplasmic enzyme availability 
- based on a random distribution in the aqueous phase - are not true in stressed and 
stationary phase yeast. Investing whether a similar phase change restructures cytoplasmic 
protein architecture inside organisms in quiescence and stress would be a fascinating 
basic research project with obvious health implications if found in human cells. 
Future work to test the generality of the storage body hypothesis would be useful to 
concisely establish if any foci are storage bodies. One possible experiment to accomplish 
this would be a mass spectrometry assay of pulse-chase labeled proteins partitioning 
between soluble and insoluble phases in starved compared to re-fed cells.  
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METHODS 
Media and yeast strains 
Yeast strains had a genetic background of BY4741 [genotype, MATa his3_1 
leu2_0 met15_0 ura3_0].  Strains expressing GFP-tagged proteins were obtained from the 
OpenBiosystems GFP collection. Rich (YPD) medium containing Yeast Extract (1%), 
Peptone (2%) and glucose (2%) was purchased from Sunrise Sciences. Synthetic 
complete medium (SC) contained 1x Yeast Nitrogen Base (BD Biosciences/Difco) 
without amino acids, synthetic drop-out medium supplement mix (Sigma) with (or 
without) glucose (2%) or was purchased premixed from Sunrise Biosciences. Cultures 
were started from by picking from freezer stocks into YPD and growing overnight before 
transferring to new media for regrowth.  All cultures were maintained shaking at 30°C 
unless otherwise specified.  
   
Foci induction by metabolite depletion 
 Select GFP-tagged strains were picked into a96-well plate and grown overnight in 
YPD. Cultures from this plate were divided into a dozen plates for storage single use 
glycerol stocks. For each experiment a plate was thawed and used to inoculate a YPD 
plate for overnight growth. Overnight cultures were used to inoculate a new plate to 0.2 
OD/ml in YPD or SC for nutrient dropout and SC growth to stationary phase. For media 
exchange experiments, cells were regrown to approximately 1 OD/ml in SC, washed once 
with the destination media, and then resuspended in SC minus the specified metabolite 
for two hours to induce foci. Cells were fixed with 4% formaldehyde (SPI-CHEM) at 
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room temperature for 60 min, and washed with PBS before storing in PBS at 4C until 
imaging. 
Cells were imaged on either a Nikon E800 fluorescence microscope with Photometrix 
Coolsnap CCD camera under oil immersion at 100x magnification or on a Nikon 
TE2000-E with a Photometrics Cascade II camera under oil immersion at 60x 
magnification. Differential interference contrast and widefield fluorescent images were 
collected using standard filter sets and processed using Nikon Elements AR. 
 
Colocalization experiments 
Strains for testing colocalization were created by transforming strains from the GFP 
collection with a high copy plasmid (pRS426) expressing Ade4-mCherry under the 
control of the GPD promoter. Strains were grown 48 hours in SC-uracil to stationary 
phase to induce foci, fixed and imaged as above. 
 
Immunoprecipitation of GFP-tagged proteins 
Strains from the GFP collection or the parental strain BY4741 were cultured in SC 
medium to stationary phase (48 hours) at 30˚C to reach 100OD of cells per sample. Foci 
formation was verified by microscopy before lysing cells by vortexing with glass beads 
in 50mM Tris, 50mM NaCl, 5mM MgCl2, 1X Protease Inhibitor Cocktail 
(CalBiosciences), and 1mM DTT. After verifying by microscopy that foci were retained 
in the lysate, GFP-tagged proteins were immunoprecipitated with 4µg rabbit anti-GFP 
antibodies (Sigma) bound to 200µl Protein A-conjugated Dynabeads 
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(Immunoprecipitation Kit, Invitrogen) according to the manufacturer’s instructions. 
Immuno-precipitated proteins were washed three times with PBS (pH 7.4), and eluted by 
incubating beads in 120µl 50% trifluoroethanol at 70oC for 10 minutes. For Western blot 
verification, samples were eluted by boiling protein-A beads in SDS-PAGE loading 
buffer for 5 minutes and detected with mouse anti-GFP primary antibodies (Covance) and 
horseradish-peroxidase conjugated goat anti-mouse secondary antibodies (Santa Cruz 
Biotechnology), visualized by luminol (Santa Cruz Biotechnology). 
To measure the relative enrichment of proteins between the GFP-tagged strains 
and the untagged parental strain, we compared spectral counts of a given protein between 
samples [144] as described below. Proteins with Z ≥ 2.0 were significantly enriched 
(97.7% confidence level) by immunoprecipitation.   
 
Heat shock experiments 
For heat shock experiments, cultures were restarted in SC to 0.2 OD/ml in triplicate for 
each strain, regrown to approximately 1 OD/ml, and transferred to shaking incubators at 
either 30 oC or 42 oC for two hours. For mass spectrometry, cells were lysed as described 
above and fractionated to recover a soluble and an insoluble faction for each sample as 
previously described [1]. To measure foci induction, cells from the various GFP strains 
were fixed and imaged as described above. 
Mass spectrometry  
Proteins from whole cell lysates and immunoprecipitation were prepared for mass 
spectrometry denaturing with 50% trifluoroethanol (TFE) (v/v). Proteins were reduced 
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with 15 mM DTT at 65°C for 45 min and alkylated with 55 mM iodoacetamide at for 30 
min on the bench. Samples were diluted 10-fold with digestion buffer (50 mM Tris–HCl 
pH 7.8, 2 mM CaCl2) and digested with with 2 µg Proteomics Grade trypsin (Sigma) 
during a 4h incubation at 37°C or overnight on the bench. Trypsin activity was halted by 
the addition of 1% formic acid, and sample volume was reduced to ~100 µl by SpeedVac 
centrifugation. Samples were resuspended to 150 µl with Buffer C (95% H2O, 
5% acetonitrile (ACN), 0.1% formic acid). To remove undesirable contaminants, digested 
samples were cleaned up by reverse phase chromatography on Hypersep C18 Columns 
(Thermo). Whole cell lysates were also filtered on Microcon 10 kDa Spin Tubes 
(Millipore).   
LC/MS/MS analysis of whole cell lysate samples and Gln1-GFp IP samples was carried 
out on an Eksigent nanoflow LC system connected to an LTQ-Orbitrap XL (Thermo) as 
previously described [144]. Each biological replicate was sampled by four injections. 
LC/MS/MS analysis of the remaining IP samples were carried out on an Eksigent 
nanoflow LC system connected to an LTQ-Orbitrap Velos (Thermo).  
 
Bioinformatic analysis 
Spectra from the whole cell lysate were searched against the non-redundant yeast protein-
coding data set downloaded from SGD (http://www.yeastgenome.org/download-data/) 
using the SEQUEST search algorithm. Search results were submitted to PeptideProphet 
[145] and ProteinProphet [146] using TPP  and filtered to 1% false positive rate. 
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Spectra from IP samples were searched using the MSBlender search algorithm against the 
same protein coding data set. MSBlender searches were carried out using TIDE, MS-
GFDB, and InsPecT search algorithms and filtered to a 1% false discovery rate[147]. 
 
Generation of protein lists 
For each biological replicate LC-MS/MS injections were analyzed independently. Data 
from multiple injections per biological replicate were combined by summing the spectral 
counts across injections. All data sets within an experiment were aligned, and proteins 
observed in only one biological replicate injection were removed. For whole cell lysate 
samples, the data sets were curated to assign all peptides to a single unique protein or 
protein group to account for the occurrence of degenerate peptides assigned to multiple 
proteins (e.g. paralogs). For IP samples, peptide counts were divided evenly among all 
protein group members sharing that common peptide.  
 
Protein quantification 
Proteins were quantified by comparison of spectral counts, as described in Lu et al. 
2007[144]. Briefly, observed frequencies for each protein were calculated as the of sum 
spectral counts across biological replicates. Then each protein was given an additional 
pseudo-count of 1 spectral count to adjust for proteins with a zero-count. Z-scores were 
calculated for each protein by comparing its relative frequency in the sample to a 
matched control (e.g. GFP strain vs. untagged control or soluble fraction vs. insoluble 
fraction). A z-score of >±1.96 was set as the threshold for significance. Composite Z-
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scores for fractions were then calculated as the sum individual Z-scores per for each 
biological replicate divided by the square root of the number of Z-scores combined. For 
the heatshock experiments the differential Z-scores between the 30C and 42C samples 
were then calculated as the difference between composite Z-scores, again normalized by 
the number of Z-scores combined (i.e. 2). 
 
Ontology annotation and enrichment calculation 
GO term enrichment for among foci forming proteins was calculated with 811 
cytoplasmic proteins as a background set with the Bonferroni multiple hypothesis test 
correction using the BinGO plugin in Cytoscape against the Yeast GO slim database. 
 
Fluorescence activated cell sorting and imaging cells 
To determine the effects of increasing cell age on the prevalence of possessing Gln1-GFP 
foci we grew cultures of Gln1-GFP to stationary phase in YPD (5 days) and fixed as 
described above. Bud scars on cells were fluorescently marked by the addition of 
calcofluor white (100µl/ml PBS cell suspension) and incubating 20 minutes. Then, by 
FAC sorting the brightest 1% of calcofluor white fluorescent cells, we collected a 
population enriched in old cells.  Cells were imaged as described above with the addition 
capture of calcofluor white fluorescence using a standard DAPI filter set to image bud 
scars. To improve bud scar and foci imaging, 15 µm deep Z-stacks of 3µm thick slices 
were captured for each imaged field. Maximum intensity projections were calculated for 
each Z-stack and, together with the raw data, used to measure cell size (as estimated by 
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cross sectional area at the focal plane), number of bud scars, and Gln1-GFP foci per cell 
in the populations. 
 
Measuring the effects of Rapamycin on foci formation by imaging flow cytometry 
Gln1-GFP cultures were restarted to 0.2 OD/ml in SC in triplicate and grown to 
approximately 1 OD/ml in SC before addition of rapamycin (Sigma) in DMSO to reach 
final concentrations of 200, 100, 20, 1, 0nm rapamycin (DMSO only), and no DMSO. 
Cells were grown an additional 30h until cultures had passed the diauxic shift before 
fixing as described for the other foci induction experiments. Cells were imaged on an 
Amnis ImageStream at 60x in brightfield and GFP channels. For all replicates 50,000 cell 
images were collected per sample in one session. Images were analyzed in Amnis IDEAS 
4.0 software using custom templates to filter images for proper focus, viability, to sort 
populations by foci phenotype, and quantify various properties of the fluorescence signal, 
such as the mean max pixel intensity. The percent of cells with foci was calculated as the 
number of cells with greater than 30% of total cellular GFP fluorescence signal in an area 
less than approximately 1.25 µm2. To be precise the gate for the foci size scales with 
integrated fluorescence intensity (F) by the equation: 
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where (F) is the integrated fluorescence intensity of smallest number of contiguous pixels 
that account for at least 30% of total cellular fluorescence and (A) is the sum of the area 
of those pixels.  
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SUPPORTING INFORMATION 
 
 
 
 
 
GO Term   p-Value Genes/term 
cellular amino acid metabolic process [GO:0006520] 3.00E-15 43 
cellular amine metabolic process [GO:0044106] 4.80E-15 44 
amine metabolic process [GO:0009308] 1.68E-14 45 
carboxylic acid metabolic process [GO:0019752] 2.19E-13 48 
oxoacid metabolic process [GO:0043436] 2.19E-13 48 
organic acid metabolic process [GO:0006082] 2.43E-13 48 
cellular ketone metabolic process [GO:0042180] 7.26E-13 49 
small molecule metabolic process [GO:0044281] 2.03E-09 64 
cellular nitrogen compound biosynthetic process[GO:0044271] 1.07E-07 35 
regulation of translation [GO:0006417] 2.72E-05 18 
tRNA aminoacylation for protein translation[GO:0006418] 6.03E-05 11 
amine biosynthetic process [GO:0009309] 7.55E-05 21 
glutamine metabolic process [GO:0006541] 1.18E-04 9 
amino acid activation [GO:0043038] 1.42E-04 11 
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tRNA aminoacylation [GO:0043039] 1.42E-04 11 
cellular amino acid biosynthetic process [GO:0008652] 2.54E-04 20 
organic acid biosynthetic process [GO:0016053] 2.66E-04 23 
carboxylic acid biosynthetic process [GO:0046394] 2.66E-04 23 
posttranscriptional regulation of gene expression[GO:0010608] 3.40E-04 18 
small molecule biosynthetic process [GO:0044283] 1.81E-03 26 
glutamine family amino acid metabolic process[GO:0009064] 2.14E-03 12 
IMP biosynthetic process [GO:0006188] 4.75E-03 6 
IMP metabolic process [GO:0046040] 4.75E-03 6 
nucleoside monophosphate biosynthetic process[GO:0009124] 6.61E-03 9 
regulation of translational initiation [GO:0006446] 8.02E-03 7 
purine ribonucleoside monophosphate biosynthetic 
process [GO:0009168] 
8.02E-03 7 
purine nucleoside monophosphate biosynthetic process [GO:0009127] 1.14E-02 7 
purine ribonucleoside monophosphate metabolic process [GO:0009167] 1.14E-02 7 
biosynthetic process [GO:0009058] 1.17E-02 100 
nucleobase-containing compound biosynthetic process [GO:0034654] 1.18E-02 15 
ribonucleoside monophosphate biosynthetic process[GO:0009156] 1.27E-02 8 
regulation of cellular protein metabolic process[GO:0032268] 1.29E-02 20 
nucleoside monophosphate metabolic process[GO:0009123] 1.31E-02 9 
nucleotide biosynthetic process [GO:0009165] 1.44E-02 14 
purine nucleoside monophosphate metabolic process[GO:0009126] 1.60E-02 7 
ribonucleoside monophosphate metabolic process[GO:0009161] 1.65E-02 8 
translational initiation [GO:0006413] 2.50E-02 11 
regulation of protein metabolic process [GO:0051246] 2.72E-02 20 
protein refolding [GO:0042026] 3.08E-02 6 
Table S2.1. GO enrichment for foci forming proteins  
 
Systematic  
name 
Gene 
Name 
Systematic  
name 
Gene 
Name 
Systematic  
name 
Gene 
Name 
Systematic  
name 
Gene 
Name 
YMR120C ADE17 YER023W PRO3 YIL052C RPL34B YIL069C RPS24B 
YMR300C ADE4 YGL062W PYC1 YDL191W RPL35A YGR027C RPS25A 
YGR061C ADE6 YBR218C PYC2 YDL136W RPL35B YLR333C RPS25B 
YMR169C ALD3 YLR075W RPL10 YLR325C RPL38 YGL189C RPS26A 
YPR145W ASN1 YPR102C RPL11A YPR043W RPL43A YER131W RPS26B 
YGR124W ASN2 YGR085C RPL11B YBR031W RPL4A YOR167C RPS28A 
YDR168W CDC37 YDL082W RPL13A YDR012W RPL4B YLR264W RPS28B 
YCR005C CIT2 YMR142C RPL13B YML073C RPL6A YJR145C RPS4A 
YLR216C CPR6 YKL006W RPL14A YLR448W RPL6B YHR203C RPS4B 
YML070W DAK1 YHL001W RPL14B YGL076C RPL7A YPL090C RPS6A 
YHR068W DYS1 YIL133C RPL16A YHL033C RPL8A YBR181C RPS6B 
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YPL037C EGD1 YKL180W RPL17A YLL045C RPL8B YNL096C RPS7B 
YMR250W GAD1 YJL177W RPL17B YGL147C RPL9A YBL072C RPS8A 
YDL215C GDH2 YNL301C RPL18B YDL130W RPP1B YER102W RPS8B 
YPR160W GPH1 YBL027W RPL19B YOL039W RPP2A YPL081W RPS9A 
YKL152C GPM1 YPL220W RPL1A YMR230W RPS10B YBR189W RPS9B 
YLR192C HCR1 YGL135W RPL1B YDR025W RPS11A YOR007C SGT2 
YCL030C HIS4 YMR242C RPL20A YBR048W RPS11B YAL005C SSA1 
YLL026W HSP104 YOR312C RPL20B YMR143W RPS16A YNL209W SSB2 
YPL240C HSP82 YBR191W RPL21A YDL083C RPS16B YLR150W STM1 
YFR053C HXK1 YPL079W RPL21B YML024W RPS17A YBR126C TPS1 
YBL076C ILS1 YLR061W RPL22A YDR447C RPS17B YML100W TSL1 
YLR432W IMD3 YGL031C RPL24A YDR450W RPS18A YJR103W URA8 
YML056C IMD4 YGR148C RPL24B YML026C RPS18B YJR014W YJR014W 
YOR232W MGE1 YLR344W RPL26A YML063W RPS1B YOR251C YOR251C 
YJL042W MHP1 YGR034W RPL26B YKR057W RPS21A YPL009C YPL009C 
YER165W PAB1 YDR471W RPL27B YJL136C RPS21B YNL241C ZWF1 
YGR087C PDC6 YOR063W RPL3 YGR118W RPS23A   
YGR240C PFK1 YLR406C RPL31B YPR132W RPS23B   
YMR205C PFK2 YOR234C RPL33B YER074W RPS24A   
 
Table S2.2. Roughly a third of detectable cytoplasmic proteins (117/395) became 
more insoluble following a 2hr heatshock. 
 (95% confidence level, Z-score >1.96) 
 
 
Systematic 
Name 
Gene 
Name 
YGL234W ADE5,7 
YOR335C ALA1 
YGL105W ARC1 
YDR127W ARO1 
YGR155W CYS4 
YPR035W GLN1 
YCL030C HIS4 
YMR186W HSC82 
YDR171W HSP42 
YPL240C HSP82 
YER165W PAB1 
YDR450W RPS18A 
YHL034C SBP1 
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Systematic 
Name 
Gene 
Name 
YAL005C SSA1 
YDL229W SSB1 
YNL209W SSB2 
YKL081W TEF4 
YIL078W THS1 
YJL130C URA2 
YGR094W VAS1 
YGR234W YHB1 
  
Table S2.3. Among the 50 cytoplasmic proteins that co-immunoprecipitate with 
Hsp82-GFP, a significant number, 21, also form foci. 
 (p<4.0E-3; 97.7% confidence level, Z-score ≥ 2.0) 
 
 
 
 
Systematic 
Name 
Gene 
Name 
Systematic  
Name 
Gene 
Name 
YOR335C ALA1 YMR309C NIP1 
YOL058W ARG1 YER165W PAB1 
YDR127W ARO1 YGR240C PFK1 
YDR380W ARO10 YMR205C PFK2 
YGL202W ARO8 YDL055C PSA1 
YPR145W ASN1 YGL062W PYC1 
YGR124W ASN2 YBR079C RPG1 
YGR142W BTN2 YHL033C RPL8A 
YOL139C CDC33 YOL121C RPS19A 
YAL012W CYS3 YHR021C RPS27B 
YDL160C DHH1 YOR167C RPS28A 
YJR137C ECM17 YLR388W RPS29A 
YPL037C EGD1 YBL072C RPS8A 
YHR193C EGD2 YER043C SAH1 
YKL182W FAS1 YLR180W SAM1 
YAL035W FUN12 YOR184W SER1 
YER025W GCD11 YIL074C SER33 
YGL195W GCN1 YAL005C SSA1 
YFR009W GCN20 YNL209W SSB2 
YDL171C GLT1 YPL106C SSE1 
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YBR121C GRS1 YHR064C SSZ1 
YCL030C HIS4 YLR150W STM1 
YIL116W HIS5 YBR143C SUP45 
YER052C HOM3 YKL081W TEF4 
YLL026W HSP104 YGR162W TIF4631 
YLR432W IMD3 YBL039C URA7 
YPL145C KES1 YBR025C YBR025C 
YER036C KRE30 YDR071C YDR071C 
YGR264C MES1 YGR285C ZUO1 
YJR010W MET3   
 
 
Table S2.4. Arsenic stress induces aggregates among 59 cytoplasmic proteins 
Aggregation of individual proteins was measured by an insoluble shift in fractionated 
whole cell lysate relative to unstressed control in shotgun mass spectrometry by Jacobson 
et al. 2012. 
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Chapter 3: Protein aggregation as a widespread and conserved part of 
aging 
INTRODUCTION 
Age dependent neurodegeneration is often cause by the buildup of aggregated 
proteins. In these diseases aggregated proteins, such as polyglutamine in Huntington’s or 
A-beta in Alzheimer’s, accumulate within nerve cells in the brain leading to nerve cell 
death [148],[149]. Additionally, non-disease associated proteins have been detected co-
aggregating with disease causing aggregates [150], [151], suggesting an interplay 
between general protein aggregation and disease specific protein aggregation. While 
specific disease associate protein aggregates have been shown to cause cell death in 
across species [125], [148], [152], general protein aggregation during normal remains 
largely unstudied [153].  
As organisms age the processes controlling proteostasis deteriorate.  Chaperone 
expression often decreases with age [121]. Autophagy and proteasome activity decline as 
well, reducing protein degradation rates in older cells [123]. Older animals also 
accumulate oxidatively damaged proteins [154] which resist degradation and inhibit 
proteasomes [94], [155].  Finally, there is evidence from a study of bacterial inclusion 
bodies that protein aggregation precedes oxidation [156]. Together these findings suggest 
proteins in general may be more likely to aggregate with age. 
A recent study in Caenorhabditis elegans measured age dependent increases in 
protein aggregation [125]. The amount of several hundred insoluble proteins increased in 
adult worms as they aged.  The authors confirmed the buildup of insoluble proteins was 
due to protein aggregation and furthermore, demonstrated an increase in aggregation of 
non-disease associated proteins enhanced the toxicity of a disease associated protein. 
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Widespread protein insolubility and aggregation increases in normally aging worms, 
raising the possibility that general protein aggregation is an inherent part of aging which 
may contribute to the onset of neurodegenerative diseases. 
We hypothesized that if protein aggregation is indeed a general mechanism of 
cellular aging, we should observe an increase in protein aggregation in other organisms, 
such as aging yeast cells. To test this hypothesis we measured the solubility of proteins in 
yeast growing in liquid culture over the course of 60 hours by shotgun gun mass 
spectrometry. Protein insolubility increasing with age can be used to profile age 
dependent aggregation [25].  In accordance with our hypothesis, we observed widespread 
protein insolubility in the aging yeast; over 15 percent of cytoplasmic proteins were 
insoluble at any point from late log phase into stationary phase. Interestingly, the 
particular proteins in the insoluble fraction generally changed with time.   
We identified 90 cytoplasmic proteins that become progressively more insoluble 
with age in yeast. We then compared this set of proteins with a similar set of age 
dependent protein aggregates discovered in C. elegans discovered by David et al. [125] to 
look for conserved protein aggregation propensities.  Indeed, a significant number of 
orthologous proteins were shared between both sets. Our data provides the first known 
evidence of conservation of age dependent protein insolubility in normal cellular aging. 
Finally, we looked for correlations between protein aggregation and longevity by 
bioinformatic analysis of co-occurring phenotypes in genetic screens in yeast. I.e., can a 
knock-down phenotype associated with a particular set of genes predict the genes 
associated with longevity? In our most significant result, we discovered that genetic 
manipulations increasing thermotolerance in yeast are likely to also increase lifespan. Our 
results suggest that cellular mechanisms that confer protein stability have potential to 
increase longevity.  
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RESULTS AND DISCUSSION 
Measuring protein insolubility in yeast during aging. 
Yeast cultures grow logarithmically as long as glucose is available to fuel rapid 
energy production, but as the glucose runs out cells are forced to transition to a reparative 
oxidation of ethanol. This change in metabolism, called a diauxic shift, can be observed 
as an inflection in the growth rate followed by reduced growth rate. Following the 
diauxic shift, cells that have budded once or less will typically transition to a quiescent 
state, which should be roughly 50-75% of cells in the culture, hence the reduced growth 
rate. Cells that do not transition to quiescence continue to bud until they die, but their 
subsequent daughter cells are born quiescent, further diluting the replicatively aged cells 
within the population [82]. Thus the onset of chronological aging in yeast begins 
following the diauxic shift.  
To measure changes in protein solubility with aging, we measured the relative 
solubility of proteins in yeast at late log phase (4h), past the diauxic shift at the start of 
chronological aging (24h), after 5 days of culturing (60h), and following 2 hours in fresh 
media (re-fed, 62h) (Figure 1A). Systematic protein solubility profiling was measured by 
the relative partitioning of each protein between a soluble and insoluble phase at each 
time point (Figure 1A). We showed previously that insoluble shifts detected by this 
method correlate well with protein assembly formation of cytoplasmic proteins [1], many 
of which are aggregates (Chapter 2).  
Mass spectrometry profiling of soluble and insoluble fractions produced a 
comprehensive survey of yeast proteins. Over 4000 proteins were detected throughout the 
time course, representing greater than two thirds coverage of all open reading frames in S. 
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cerevisiae, with over 1000 proteins seen at all 4 time points (Figure 1B).  To calculate the 
bias of each protein toward the soluble or insoluble fraction, we employed the APEX 
method [157]. In brief, the difference between the normalized frequency of a protein’s 
spectra observed in the soluble fraction and the normalized frequency of the same 
protein’s spectra observed in the insoluble fraction produced a Z-score defining the 
confidence of differential partitioning.   
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Figure 3-1. Extensive protein insolubility occurs in yeast even under normal growth 
conditions.  
(A) An illustration of the experimental setup for measuring protein solubility over time. 
Cultures of BY4741 growing in YPD were sampled in late log phase, past the diauxic 
shift at the entrance to stationary phase, after 5 days of growth, and following 2 hours in 
fresh media. Cell lysate from each time point was separated into soluble and insoluble 
fractions and the proteins in each fraction were systematically analyzed by shotgun mass 
spectrometry to measure the relative solubility of proteins at each time point. (B) Mass 
spectrometry profiling achieved relatively comprehensive coverage of the yeast 
proteome, with 4096 out of ~6000 total possible yeast proteins observed in one or more 
time points and over 1000 proteins observed across all 4 time points. (C) A plot of the 
percent of cytoplasmic proteins significantly enriched in either the soluble or insoluble at 
each time point shows a widespread shift of proteins toward the insoluble fraction at the 
24h time point. Surprisingly, the solubility of cytoplasmic proteins in general increased 
into stationary phase (60h) and the percent of both soluble and insoluble proteins dropped 
following re-feeding cells with fresh media for 2h. (D) A significant overlap (Cumulative 
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hypergeometric p < 2.4E-8) exists between the set of cytoplasmic proteins that are 
insoluble at 60h with those that formed foci when GFP-tagged at 60h. 
 
Plotting the global trends in cytoplasmic protein solubility shows the largest 
percentage of proteins insoluble at 24h, with ~30% of cytoplasmic proteins significantly 
insoluble (Figure 1C). This time point occurs just after the diauxic shift, when the rapid 
energy production of glycolysis ceases and cells transition to oxidative respiration. Thus 
the observed spike in protein insolubility could be attributed to the stress of energy 
depletion, a topic discussed in the next chapter. In support of this idea, we see significant 
enrichment for protein re-folding machinery in the insoluble phase at 24h (Figure 2A, C).  
The global trend between 24h and 60h was an increase in the solubility of 
cytoplasmic proteins; the percent of soluble cytoplasmic proteins increased while the 
percent of insoluble cytoplasmic proteins decreased (Figure 1C). This is somewhat 
surprising as we expected proteins to generally become more insoluble with age. 
However, there were a set of proteins that, in contrast to the general trend, became 
increasingly insoluble with age. Of these, a set of 61 proteins became increasingly 
insoluble from late log phase to 60h but increased in solubility with the addition of 
nutrients (Figure 2B). This set was enriched for proteins involved in amino acid 
metabolism and translation (Figure 2D). Looking specifically at the proteins insoluble at 
60h, we see a significant enrichment for proteins that formed foci in our previous screen 
of the GFP collection under the same conditions (Figure 1D) [1].   
To assay which proteins where irreversibly insoluble, we re-fed the 60h cultures 
of cells with fresh media. The addition of fresh media, and particularly additional 
glucose, causes the dissipation of stationary phase bodies, and return to solubility for 
many proteins [1], [158], [159]. While most cytoplasmic proteins that became insoluble 
during aging showed an increase in relative solubility following the transfer to fresh 
 113 
media, 20 proteins did not. Most of these (14/20) were translation associated proteins by 
Gene Ontology (GO) term annotation for biological process. In fact, translation 
associated proteins were the only class of proteins to be progressively more insoluble 
throughout the experiment, suggesting they are particularly prone to insolubility. 
 
 
Figure 3-2. The set of insoluble cytoplasmic proteins in yeast cells changes over time.  
(A) Comparing each protein’s Z-score across time points revealed some cytoplasmic 
proteins’ nadir of solubility occurred at 24h followed by a progressive increase in 
solubility. (B) Another set of cytoplasmic proteins became increasingly insoluble up to 
60h as measured by decreasing Z-scores over time. (C) Functional enrichment tests of 
these 50 proteins for Gene Ontology (GO) annotations were carried out with the 
hypergeometric test against the background set of 4096 proteins detected in this 
experiment. A total of 33 out of 50 proteins fell into one or more significantly enriched 
biological process categories, most notably “protein folding”. (D) A total of 43 out of 61 
proteins most insoluble at 60h fell into one or more significantly enriched biological 
process categories using the method detailed in (C), most notably “translation”. 
One caveat of the method is that mass spectrometry sampling is inherently biased 
toward observing proteins with higher concentrations. This bias further increases when 
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restricting analysis to proteins seen in multiple time points for comparing solubility over 
time. This method may especially underestimate the amount of aggregation in cells, as 
the most aggregation prone proteins are predicted to have the lowest expression levels 
[106][160].  
 
Conservation of age dependent protein insolubility between yeast and worm 
Having found a widespread increase in protein insolubility in yeast, we then 
tested for conservation of the phenomenon. The first and so far only other published 
experiment measuring general protein aggregation with age was done in C. elegans by 
David et al. [125]. David and colleagues found that the amount of insoluble proteins 
increased in adult worms as they aged from 3 days to 10 days old. They used a genetic 
trick to produce worms lacking active germline cells, so all cells in the worms were post 
mitotic and aging only chronologically. They lysed the worms at the 3 and 10 days and 
extracted the detergent insoluble proteins for comparison by mass spectrometry. They 
found several hundred proteins from many cellular compartments and tissue types 
increased in the insoluble fraction between the two time points. As further validation that 
the accumulation of insoluble proteins represents aggregation, they demonstrated several 
fluorescent-tagged proteins transitioned from diffuse to foci localization in older animals.  
To compare the set of insoluble proteins found in worms to the set we found in 
yeast, we restricted both sets to orthogroups common between the two species using 
orthogroup mappings from www.phenologs.org [161]. We were left with 226 worm 
proteins with orthologs in yeast and 90 cytoplasmic yeast proteins with orthologs in 
worm, with 35 orthologs shared by both sets (Table S3-2). A hypergeometric test shows 
this overlap is highly unlikely to occur by random chance (p < 2.4E-11), indicating 
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conservation of age dependent aggregation between the two species. We speculate that 
age dependent aggregation may in fact be a general property of aging, conserved across 
all species that exhibit senescence. A total of 27 out of the 35 proteins were annotated 
with “translational” GO biological processes, a significant enrichment among the set of 
proteins in the overlap (hypergeometric p < 2.6E-22). We rationalize that translation 
associated proteins might be evolutionarily trapped in sequence space at a high 
aggregation propensity in order to preserve their very necessary cellular function. 
Alternatively, increased exposure to unfolded nascent chains is an inherent occupational 
hazard of ribosomal proteins, which may increase the rate they are nonspecifically 
incorporated into protein aggregates. 
 
 
Figure 3-3. Increasing aggregation of particular proteins with age is conserved 
between S. cerevisiae and C. elegans.  
 
To compare between organisms we restricted the sets of insoluble proteins to only those 
with orthogroup mappings in both yeast and worm  [161].  In yeast the mapping defined a 
subset of 90 proteins that became more insoluble between 24h and 60h with an ortholog 
in worms. From the worm data of David et al. [125], the mapping produced a set of 226 
worm proteins (with a yeast ortholog) that became more insoluble between day 3 and day 
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10. A significant overlap exists between the two sets, as evidenced by a cumulative 
hypergeometric p< 2.4E-11.  
 
A genetic link between thermotolerance and aging supports general aggregation as a 
common mechanism of senescence 
Data from deletion and loss of function screens posted to the Saccharomyces 
Genome Database was curated to pool various measures of thermotolerance and lifespan 
across experiments. A significant overlap was found between thermotolerance and 
increased lifespan (hypergeometric p<7.3E-3), and an even more significant overlap 
between thermotolerance and increased chronological lifespan in particular 
(hypergeometric p<5.3E-5) (Figure 3-4). In contrast, none of the genetic perturbations 
that increased thermotolerance are known to reduce lifespan. Association rule mining 
extracted directed relationships between these pooled sets and found that increased 
thermotolerance is predictive of an increase in lifespan and chronological lifespan, as 
indicated by the confidence scores.  
Our results suggest that cellular mechanisms that confer protein stability have 
potential to increase longevity. In fact, many of the mechanisms that increase 
thermotolerance either prevent protein aggregation, such as increased chaperone 
expression [162] and trehalose production [115], or degrade protein aggregates, such as 
autophagy [163][164]. Thus mechanisms that reduce general protein aggregation may 
have the potential to influence lifespan. 
 
Interestingly, the complete lack of overlap between genetic perturbations that 
increased thermotolerance and any measure of reduced lifespan suggests attempting to 
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increase lifespan through improved thermotolerance may be a safer route to longer life 
than current pharmaceutical interventions, such as rapamycin, which suppresses immune 
function. 
Figure 3-5. Thermotolerance is predictive of lifespan increase, particularly 
chronological lifespan.  
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CONCLUSION 
The previous chapter argued that many foci are protein aggregates and, based on 
Gln1-GFP as a case study, their occurrence increases with both chronological and 
replicative age. This chapter builds on that case to argue that age dependent protein 
aggregation is a general property of many, if not all, cytoplasmic proteins and that this 
property is conserved across different species. We showed that protein insolubility is a 
common aspect of normal yeast growth, but the particular proteins that are insoluble 
generally changes with time. Within these data, we identified 90 cytoplasmic proteins 
that become more insoluble with age. These yeast proteins are orthologs of a similar set 
of proteins in C. elegans that also become increasingly insoluble with age, providing the 
first evidence that age dependent insolubility propensity is conserved. We conclude that 
widespread protein insolubility occurs even in normal conditions in aging yeast, and that 
this insoluble propensity with age is a conserved property of these proteins. 
Future work analyzing the set of evolutionarily conserved age insoluble proteins 
for structural motifs or aggregation signatures may be able to find the physiochemical 
properties responsible for aggregation of this set of proteins. Looking for commonalities  
between the conserved set found here and proteins that influence or co-aggregate with 
human diseases aggregates as evidence for an evolutionarily ancient protein aggregation 
propensity influencing human cellular senescence. 
 
METHODS 
 
Media and yeast strains 
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Yeast strains had a genetic background of BY4741 [genotype, MATa his3_1 
leu2_0 met15_0 ura3_0].  Rich (YPD) medium containing Yeast Extract (1%), Peptone 
(2%) and glucose (2%) was purchased from Sunrise Sciences. Cultures were started from 
by picking from freezer stocks into YPD and growing overnight before transferring to 
new media for regrowth.  All cultures were maintained shaking at 30°C unless otherwise 
specified.  
 
Liquid Culture Time Course  
Yeast cultures were for the time course were started as described above to an initial 
optical density (O.D.) of 0.2 per ml in 500ml YPD as a pair of biological replicates. 
Sampling of cultures took place ~ 4h after starting when cells reached late log phase (1 
O.D./ml), at 24h once cells had passed the diauxic shift, at 60h, and again after 
resuspending cells in fresh media for 2h. At each time, we measured the O.D. and 
withdrew culture media containing 100 O.D. worth of cells (e.g 100ml at the first time 
point). Centrifuging cells for 5 minutes at 1000x g produced a loose cell pellet. The pellet 
was washed in lysis buffer, lysed by bead beating, and fractioned as described in for the 
heat shock experiment in the preceding chapter. 
 
Mass spectrometry  
Preparing proteins for mass spectrometry analysis proceeded precisely as described in the 
preceding chapter for the LTQ-Orbitrap XL (Thermo) . 
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Bioinformatic analysis of peptides 
Spectra from the whole cell lysate were searched against the non-redundant yeast protein-
coding data set downloaded from SGD (http://www.yeastgenome.org/download-data/) 
using the SEQUEST search algorithm. Search results were submitted to PeptideProphet 
[145] and ProteinProphet [146] using TPP  and filtered to 1% false positive rate. 
Spectra were searched using the MSBlender search algorithm against the same protein 
coding data set. MSBlender searches were carried out using TIDE, MS-GFDB, and 
InsPecT search algorithms and filtered to a 1% false discovery rate[147]. 
 
Generation of protein lists 
For each biological replicate LC-MS/MS injections were analyzed independently. Data 
from multiple injections per biological replicate were combined by summing the spectral 
counts across injections. All data sets within an experiment were aligned, and proteins 
observed in only one biological replicate injection were removed. For peptide counts 
matching to paralogs or protein groups sharing tryptic sequences, peptide counts were 
divided evenly among all protein group members sharing the common peptide.  
 
Protein quantification 
Proteins were quantified by comparison of spectral counts, as described in Lu et al. 
2007[144]. Briefly, observed frequencies for each protein were calculated as the of sum 
spectral counts across biological replicates. Then each protein was given an additional 
pseudo-count of 1 spectral count to adjust for proteins with a zero-count. Z-scores were 
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calculated for each protein by comparing its relative frequency in the sample to a 
matched control (e.g. GFP strain vs. untagged control or soluble fraction vs. insoluble 
fraction). A z-score of >±1.64 (90% confidence interval) was set as the threshold for 
significance. Composite Z-scores for fractions were then calculated as the sum 
individual Z-scores per for each biological replicate divided by the square root of the 
number of Z-scores combined. For the comparing between time points experiments, 
differential Z-scores were then calculated as the difference between composite Z-scores, 
again normalized by the number of Z-scores combined (e.g. proteins more insoluble over 
between 24h and 60h would be calculated as ∆Z60h-24h = Z60h - Z24h). 
 
Ontology annotation and enrichment calculation 
GO term enrichment for among foci forming proteins was calculated with the 4096 
proteins detected in this set of experiments as a background set with the Bonferroni 
multiple hypothesis test correction using the BinGO plugin in Cytoscape against the 
Yeast GO slim database. GO term enrichment was calculated similarly for conserved 
aggregating proteins but using the 1857 C. elegans orthogroup mappings to S. cerevisiae 
as the background set. 
 
 
Ortho-group mapping of aggregating proteins between S. cerevisiae and C. elegans 
Ortholog matching between yeast and worm proteins used the orthogroup mapping 
developed by McGary et al. 2010.  From our yeast data we selected the set of cytoplasmic 
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proteins that became relatively more insoluble between 24h to 60h to compare with the 
set of proteins David et al. 2010 observed an increase in counts in the insoluble fraction 
between young and old worms. Protein sets were mapped to the orthologs common 
between yeast and worm using http://www.phenologs.org/ [161]. This produced subsets 
of the insoluble proteins from each experiment that have orthogroup mappings between 
worm and yeast. To compare the significance of the similarity between the sets we 
calculated the hypergeometric probability of the overlap using the 1857 Ce-Sc.Sc 
orthogroups from http://www.phenologs.org/as the background.  
 
Association rule mining of genetics screens for relationships between 
thermotolerance and lifespan in yeast 
Original SGD phenotypes were downloaded as phenotype_data.tab 
from http://www.yeastgenome.org/download-data/curation in June 2012. Phenotypes 
were processed to include only those resulting from “null” or “reduction of function” 
mutations, and to include only ORFs. Additional processing was performed to 
consolidate all related ‘heat sensitivity’ and ‘thermolerance’ phenotypes. Association 
rules were mined from these processed phenotypes. To find rules, gene-phenotype 
associations were formatted to treat each gene as a transaction, and their associated 
phenotypes as ‘purchased’ items. Rules associating phenotypes were then obtained using 
the R package ‘arules’ with the ‘apriori’ algorithm. An item set size limit of two 
phenotypes was used for rule discovery. The confidence score of each rule was used to 
assess directionality. Confidence scores were calculated as the frequency of proteins in 
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the intersection divided by the total proteins in the source set. For example, 
conf(chronological longevity→thermotolerance) =  supp(longevityUthermotolerance)/sup(longevity) = 
5/100 = 0.05. To measure significance of overlap without regard to directionality, the 
cumulative hypergeometric probability of the overlap for each rule was computed. 
 
Author’s contributions 
The association-rule mining experiment was designed by Mark Tsechansky and Jon 
Laurent and executed by Jon Laurent. All other work was the author’s. 
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SUPPLEMENTAL INFORMATION 
Systematic 
Name Gene 
YLR388W RPS29A 
YCR077C PAT1 
YGR189C CRH1 
YLR257W   
YER052C HOM3 
YOL121C RPS19A 
YNL302C RPS19B 
YHR021C RPS27B 
YDL082W RPL13A 
YER176W ECM32 
YIL069C RPS24B 
YMR194W RPL36A 
YPL131W RPL5 
YER074W RPS24A 
YGR034W RPL26B 
YOR091W TMA46 
YKL204W EAP1 
YPR163C TIF3 
YOR232W MGE1 
YIL135C VHS2 
  
Table S2.1. Proteins that become increasingly insoluble in aging yeast and do not 
remain insoluble after addition of nutrients. 
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Systematic 
Name Gene 
Systematic 
Name Gene 
YJR105W ADO1 YLR325C RPL38 
YAL003W EFB1 YPL131W RPL5 
YOR133W EFT1 YGL076C RPL7A 
YDR385W EFT2 YPL198W RPL7B 
YOR317W FAA1 YDR382W RPP2B 
YJR070C LIA1 YDR064W RPS13 
YOR310C NOP58 YOL040C RPS15 
YLR029C RPL15A YML026C RPS18B 
YMR121C RPL15B YOL121C RPS19A 
YNL301C RPL18B YNL302C RPS19B 
YBL027W RPL19B YER074W RPS24A 
YBL087C RPL23A YIL069C RPS24B 
YER117W RPL23B YJR123W RPS5 
YBL092W RPL32 YKL117W SBA1 
YER056C-A RPL34A YGR192C TDH3 
YIL052C RPL34B YKL056C TMA19 
YDL191W RPL35A YOR332W VMA4 
YDL136W RPL35B   
Table S2.2. Proteins that show a conserved pattern of increasing aggregation with 
age in both yeast and worm.  
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 Chapter 4: Cellular Energy Buffers Protein Aggregation Propensity: 
Rappelling over the “edge” 
INTRODUCTION 
The central importance of amyloidal and prion proteins in neurodegenerative 
diseases is widely recognized, and the number of diseases linked to protein aggregation is 
growing continuously [155]. Interestingly, evidence is building that protein aggregation 
in vivo may be far more common than expected, with protein aggregation implicated as 
the proximal cause of cell death in progeria [165], some types of cardiovascular diseases 
[166], and stroke [167]. 
 
Cells possess many active strategies for controlling protein aggregation, ranging 
from molecular chaperones to a diverse array of subcellular compartments for storing, 
degrading, and perhaps recovering aggregated proteins [168][108]. Recent evidence has 
also begun building for the evolutionary signatures associated with widespread protein 
aggregation[169][170]. In a particularly seminal paper, Tartaglia et al. demonstrated a 
surprising anti-correlation between the cellular expression levels of a set of eleven human 
proteins and their aggregation rate in vitro [106]. They observed that each protein was 
naturally expressed in vivo at levels strongly correlated to its solubility, defining a 
solubility boundary which they dubbed the “edge” (Figure 1), with highly aggregating 
proteins maximally expressed at low levels, and less aggregating proteins maximally 
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expressed at higher levels. This hypothesis suggests that proteins which are likely to form 
aggregates due to their physiochemical properties, all else being equal, will be 
constrained to lower abundances than proteins with a lower natural propensity to 
aggregate. One surprising aspect was that protein expression levels were not simply 
bounded by the “edge,” but rather they were uniformly found to be on the “edge”, 
suggesting a balance of evolutionary selection between protein expression and 
aggregation propensity. 
 
                     
Figure 4-1. “Life on the edge” concept .   
Tarteglia et al. demonstrated an inverse relationship between protein concentration, as 
measured by mRNA expression, and in vitro protein aggregation rate. They put forward 
the idea that cells have evolved to maintain in vivo protein aggregation propensity at the 
limits of solubility or “the Edge” (shown as a green line) (adapted from [106]). 
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While most (nine) of the proteins initially tested were known to be involved in 
protein aggregation diseases, more recent evidence suggests that the “edge” hypothesis 
might apply more broadly than to these largely pathological proteins. Perhaps the 
strongest support for increased generality of the observation came from a consideration of 
E. coli mRNA abundances, which showed a consistent anti-correlation with aggregation 
propensity, to the extent that mRNA levels could be in part predicted based upon 
predicted aggregation propensities [160]. 
 
Given each protein’s inherent propensity to aggregate, the “edge” (i.e., the 
abundance level above which proteins will be significantly more likely to aggregate) may 
not be fixed. Rather, the “edge” may depend upon the state of the cell, specifically its 
energy state and the availability of agents that are instrumental in dissolving aggregates, 
such as chaperones, proteasomes, autophagy, and so on. Thus, a simple but seemingly 
reasonable extension to the “edge” hypothesis would include a consideration of cellular 
energy state in addition to protein abundance and their intrinsic physicochemical 
aggregation propensities. For instance, mildly expressing even a non-functional protein 
past its solubility limit (i.e. YFP with an increased aggregation rate) reduced growth rate 
by 2.3%, suggesting a fitness cost [143]. We posit this growth rate change results from 
energy redirected from growth into preventing aggregation and resolubilizing or 
degrading insoluble proteins.  
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We wished to test the generality of the “edge” hypothesis and to evaluate whether 
such factors as physiological and cellular state did in fact play roles in setting the “edge”. 
For these tests, we took advantage of large-scale datasets of protein localization in the 
budding yeast S. cerevisiae and the fission yeast S. pombe. Additionally, we used 
conducted in vivo experiments in S. cerevisiae, a simple and tractable model of protein 
aggregation, using microscopy and imaging flow cytometry. In particular, recent 
systematic microscopy-based screens have been performed under conditions which may 
to lead to protein aggregation. The first data set looked at ~800 yeast strains from the S. 
cerevisiae GFP-tag collection. These strains, expressed each expressing a GFP-tagged 
protein from their native locus in the genome, were grown to stationary phase. Normally 
cytoplasmic proteins are distributed diffusely, but under these conditions 180 proteins 
involved in intermediary metabolism and stress response formed cytoplasmic foci [1]. 
The second data set was drawn from a protein localization screen in S. pombe of strains 
expressing inducible YFP-tagged proteins. It too showed a profusion of novel 
cytoplasmic structures. We analyzed these datasets for evidence supporting the edge 
hypothesis, then characterized in more detail one particular protein aggregate—the 
biosynthetic enzyme glutamine synthetase—for the energy dependence of crossing the 
“edge.” 
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RESULTS AND DISCUSSION 
Widespread foci formation in S. pombe YFP screen 
The cellular distribution of proteins in the fission yeast S. pombe has been 
extensively mapped using libraries of strains expressing a given fluorescently tagged 
protein [73–76].  While not searching specifically for new structures, such screening 
efforts have frequently discovered “cytoplasmic dots” in many strains. We argue these 
structures are widespread aggregation, due in part to the conditions under which 
localization was measured and the predicted aggregation propensities of foci forming 
proteins compared to non-foci forming proteins. We focused on the screen by Matsyama 
et al. 2006 for which the image data, annotations, and expression levels were made 
publicly available. In this S. pombe screen, the strongly inducible nmt1 promoter 
connected to open reading frames (ORFs) was cloned into the genome at the leu1 locus 
with a C-terminal YFP tag to create a library of 4431 clones, each expressing a different 
YFP labeled protein[73]. We re-analyzed the data for cytoplasmic dots or fibers and 
found over 500 proteins matching these phenotypes (Figure 2).  Interestingly, many of 
these structure-forming proteins are orthologs of structure-forming proteins in S. 
cerevisiae (e.g., CTP synthase and Ade4p [1]).  
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Figure 4-2. Many green or yellow fluorescent protein (YFP or GFP)-tagged proteins 
formed cytoplasmic structures in S. pombe or S. cerevisiae, respectively.  
Fluorescence microscopy images Ade4-YFP foci (A) and Pil1-YFP fibers (B) are 
representative examples of the phenotypes in S. pombe. (adapted from [73]).  In S. 
cerevisiae similar phenotypes are seen for Ade4-GFP (C) and Asn2-GFP (D) (adapted 
from[1], scale bar for C and D is 10µm). 
 
The sets of foci and fiber forming proteins in S. pombe and S. cerevisiae possess 
properties of aggregates 
Several lines of evidence support the notion that foci from large-scale screens are 
the result of aggregation we applied the TANGO algorithm [142] to predict the 
aggregation propensity protein. TANGO employs a statistical mechanics model for 
predicting aggregation propensities of peptides. This model assumes the possibility of 5 
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conformations of a given peptide sequence within a small evaluation window and assigns 
a score to the residue in the center based on the probability of each conformation. The 
window steps sequentially across the protein sequence to create a profile of aggregation 
prone regions within a protein. The algorithm was trained on empirical analysis of in 
vitro peptide aggregation and has proved successful in predicting protein aggregation 
propensity of mutant form of several proteins, and has been widely used for aggregation 
prediction [171][172].  TANGO scores were elevated for foci-formers in both S. 
cerevisiae and S. pombe, suggesting many of the foci represent aggregates (Figure 3A, 
Mann-Whitney U test, p < 1.0E-4, and 1.0E-7, respectively).   
 
Consistent with the life-on-the-edge hypothesis, the normal S. cereviseae cellular 
abundances of foci-forming proteins are lower than the non foci-forming proteins (Mann-
Whitney U test, p < 1.0E-8). Similarly the relative abundances of proteins in the S. pombe 
over-expression screen are lower for foci-forming compared to non foci-forming proteins 
(Mann-Whitney U test, p < 1.0E-16, Figure 3B). The trends in both experiments support 
GFP-protein foci as aggregates as predicted by the “life on the edge” hypothesis of a 
proteome wide solubility constraint on protein expression. 
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Figure 4-3. Foci forming proteins in S. cerevisiae and S. pombe show an inverse 
relationship between abundance and aggregation propensity predicted by “the 
edge” for general protein aggregation.  
(A) Aggregation propensity predicted using the TANGO algorithm for cytoplasmic 
proteins in S. cerevisiae and all proteins in S. pombe. The mean TANGO score for foci 
forming proteins is higher than non-foci forming proteins in both screens which is 
consistent with the “edge” hypothesis’ prediction for aggregate formation. (B) 
Comparing the mean abundances for foci forming proteins and non-foci forming proteins 
shows foci forming proteins are expressed at lower concentrations.  
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The S. cerevisiae glutamine synthetase (Gln1-GFP) as a model aggregate 
To evaluate the life-on-the-edge phenomenon in more detail, we focused on the 
yeast glutamine synthetase (Gln1), which synthesizes glutamine from glutamate, 
ammonia, and ATP. We  previously observed Gln1-GFP  was diffusely distributed 
throughout the cytoplasm in log phase yeast cells but robustly formed foci in stationary 
phase yeast cells [1].  We showed previously (Chapter 3) that Gln1-GFP foci are likely 
protein aggregates based on their formation following various types of starvation and heat 
shock and co-immunopurification exclusively with Hsp90 chaperones (Figure 4). 
         
Figure 4-4. Using Gln1-GFP as a model for formation, foci composition was assayed 
by immunoprecipitation and mass spectrometry analysis.   
Z-scores were calculated for each protein based on its relative enrichment in the Gln1-
GFP immunoprecipiation samples compared to the untagged controls.  Strikingly, the 
Gln1-GFP pull-down material was dominated almost entirely by glutamine synthetase 
and one or possibly both of the molecular chaperones Hsp82 and Hsc82. No other 
proteins were detected a beyond the significance threshold (z-score > 2). 
 
 
Homogeneity is a hallmark of many purified aggregates[173]. Indeed, at high 
concentrations in vitro, E. coli glutamine synthetase is known to spontaneously assemble 
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into filaments [174], suggesting the protein may have an intrinsic propensity to self-
organize into macromolecular assemblies, although we see no evidence for filament 
formation in vivo in yeast. While a uniquely identifiable peptide was observed only for 
Hsc82p, the two HSP90 family chaperones are approximately 97% identical in sequence. 
Since nearly all observed peptides match to both proteins’ sequences, the presence of 
Hsp82p cannot be ruled out. Members of the HSP90 chaperone family are required for 
folding difficult-to-fold proteins as well as for refolding denatured proteins after stress 
[175]. Thus the homogeneity of the Gln1-GFP foci, combined with the strong enrichment 
for HSP90 chaperones and the observed transition to the insoluble phase, strongly 
suggests the foci represent mis-folded or misassembled protein aggregates rather than 
functional assemblies.  
Formation of Gln1-GFP foci depends strongly upon cellular energy levels 
Gln1 is normally expressed in exponentially growing yeast cells in rich media at 
very high levels (approx. 350 000 molecules / cell [176]). The life-on-the-edge theory 
would suggest the protein sits close to the “aggregation edge”. Given this high starting 
level of Gln1, we hypothesized that depleting cellular energy levels would lead to less 
effective protein homeostasis and a concomitant aggregation of Gln1. Indeed, we have 
previously observed Gln1-GFP to form foci both in stationary phase cells, but also when 
cells are transferred into glucose dropout medium (Figure 5A).  
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Using imaging flow cytometry, we quantified the degree of Gln1-GFP foci 
formation as a function of glucose concentration, measuring the penetrance of foci 
formation across the population of cells as a function of time (Figure 5B). We found that 
decreasing glucose concentrations led to a corresponding decrease in the onset time of 
Gln1-GFP foci formation (Figure 4C,D), providing evidence for the energy dependence 
Gln1-GFP foci formation.  
 
Figure 4.5: Testing the energy dependence of Gln1-GFP aggregate formation.  
(A) Fluorescence microscopy of Gln1-GFP tagged strains in log phase growth show for 
when starved for energy either by removing glucose from the growth media or the 
addition of a non-metabolizable competitive inhibitor, 2-deoxyglucose. (B) Schematic 
view of foci counting workflow. Approximately 50,000 images are captured per samples 
on an Amnis ImageStream and processed in an in-house built template to select the most 
in-focus cells, then individual cells, then cells that show GFP fluorescence. Cells that 
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pass these filters are graphed based on the intensity and size of the 30% intensity mask 
which distributes cells into foci and non-foci containing populations. (C) Quantifying foci 
formation over time across a range of range of glucose concentrations shows a range of 
kinetics (D) Plotting the concentration of glucose for a culture against the time to 50% 
foci penetrance reveals a correlation between energy level and the rate of foci formation. 
 
Gln1-GFP aggregates coalescence into single foci in an energy dependent manner 
We further tested the energy dependence of protein aggregation by measuring 
Gln1-GFP foci formation in response to abrupt interruptions of glycolysis, the major 
source of cellular energy in rapidly growing yeast cultures. Gln1-GFP tagged yeast cells 
growing exponentially in 2% glucose were transferred to media lacking glucose. In the 
majority of cells Gln1-GFP formed a few, intense foci as seen in the previous experiment 
(Figure 5A).  
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Figure 4-6. Cells contain more Gln1-GFP foci when glycolysis is severely 
interrupted.  
Removing glucose from the media indirectly halts glycolysis, and leads to strong 
induction of one or two Gln1-GFP foci per cell after 2h. Halting glycolysis by both 
glucose depletion and the addition of a competitive inhibitor of glucose hexokinase, 2-
deoxyglucose (2DG), not only induces foci, but leaves cells peppered with small foci 
rather than one or two large foci.  
 
Moreover, when Gln1-GFP tagged yeast cells were grown in media lacking 
glucose and containing 2DG, to mimic a state of extreme starvation, many small foci 
formed rather than single large foci as commonly seen in glucose depletion alone (Figure 
6). This suggests that small foci may represent spontaneously forming small oligomers 
that coalesce into fewer large foci in an energy dependent process. One mechanism could 
be through active transport, similar to the formation of aggresomes [177],[68]. Another 
possible mechanism could be through chaperone mediated dynamic partitioning, as seen 
in bacterial inclusion bodies [178].  In either case the energy dependent assembly of 
larger structures removes smaller, presumably more toxic aggregates [94] from the 
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cytoplasm by collecting them into a localized structure to improve cellular fitness.  Our 
observations of Gln1-GFP foci seem to show similar energy dependence for localization, 
suggesting the cell actively fights the existence for small oligomers. 
 
Extending the life-on-the-edge hypothesis to consider cellular energy state 
The “life-on-the-edge” hypothesis insightfully claims that proteins evolved to be 
at the limit of solubility in their respective cellular environments and that any increase in 
protein concentration or change in chemistry to increase aggregation rate will lead to 
insolubility and aggregation. However even in a constant environment cellular energy 
varies with cell cycle and most environments are far from constant. When cellular energy 
is high, cells can expend energy through many ATP-dependent protein quality control 
systems, such as the use of chaperones to force insoluble proteins back across the edge 
into a soluble state (Figure 7). Aggregates resistant to refolding or targeted degradation 
can still be removed from the cytosol by actively trafficking them to 
autophagosomal/lysomal bodies or into a rapidly growing list of aggregate sequestering 
structures [90][177].  When intracellular energy drops, these mechanisms can no longer 
functions to buffer proteins that have crossed the edge of solubility, and insoluble 
proteins will accumulate and begin to oligomerize [179].  
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Figure 4-7. Proposed Model: Extending the “edge” hypothesis  
along the axis of cellular energy creates a new model were proteins’  
position relative to a surface describes protein solubility/aggregation propensity. 
 
An economic metaphor of deficit spending can be used to understand the effects 
of cellular energy on protein solubility. Cells in a resource rich environment will spend 
some of their resources to produce enzymes to acquire more resources from their 
environments. Expressing enzymes at “the edge” of solubility would be a balanced 
budget. However cells can acquire more nutrients from the environment faster by 
expressing enzymes beyond the balance point (Figure 7, arrow A) as long they also 
spend on chaperones to keep them soluble. Proteins beyond the solubility limit create a 
“solubility debt” whose interest paid is cellular energy expended by chaperones and other 
proteostasis machinery to maintain solubility despite expression beyond the balance point 
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(Figure 7, arrow B). Growing cells essentially bet that the environment will continue to 
be good long enough to import and metabolize sufficient nutrients to either pay down the 
debt or subsidize the interest payments.  
 
The level of “solubility debt” a cell takes on should be proportional to perceived 
concentration of available nutrients. So there are naturally diminishing returns for 
expression of any given protein for a finite quantity of metabolite. Also, interfering with 
cells’ ability to sense nutrients should have a similar effect as starvation (e.g. rapamycin 
treatment, which mimics starvation [180] or caloric restriction [181] depending on the 
concentration and duration of treatment). Further, the more drastic the change in nutrients 
(e.g. 2% glucose to 0%), the more unexpected “solubility debt” cells will, on average, be 
stuck with, leading to faster aggregate build up (which we see for Gln1-GFP, Figure 5C) 
and more cells exiting the cell cycle, which requires efficient proteasome activity to 
proceed [182]. Indeed, rapid glucose depletion will arrest cells at any point in the cell 
cycle into G0 [158]. The model further predicts that the greater the change in nutrients, 
the more protein should aggregate proportionally extending recovery times to cell cycle 
re-entry or reducing lower probability of exiting a G0 arrest. Furthermore, if the metaphor 
is whimsically inverted to apply biological lessons to economics, structural deficits 
become a hallmark of an aging, perhaps even dying economy.  
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CONCLUSION 
In summary, we found foci forming proteins in S. cerevisiase and S. pombe 
showed the inverse relationship predicted by the “life on the edge” hypothesis for protein 
aggregation. We showed that the rate Gln1-GFP aggregates into foci is inversely 
proportional to the available concentration of glucose, demonstrating the availability of 
cellular energy affects aggregation rate in vivo. Thus we propose extending “the life-on- 
the-edge hypothesis” to include cellular energy in the estimating protein aggregation 
propensity. We further showed that severe reduction in glycolytic flux by nutrient 
depletion and addition of a competitive inhibitor of glycolysis produces many smaller 
foci per cell, suggesting an energy dependence in the agglomeration of smaller Gln1-GFP 
aggregates. Extending the energy dependence of aggregation to other proteins would 
support the generality of the phenomena observed for Gln1-GFP aggregates.  Testing for 
the energy dependent mechanisms of foci formation will be important to understanding 
mechanism yeast employs to cope with the stress of protein aggregation, with potential 
application to humans. 
METHODS 
Growth and microscopy of yeast 
Yeast strains had a genetic background of BY4741 [genotype, MATa his3_1 leu2_0 
met15_0 ura3_0].  Strains expressing GFP-tagged proteins were obtained from the 
OpenBiosystems GFP collection. Rich (YPD) medium containing Yeast Extract (1%), 
Peptone (2%) and glucose (2%) was purchased from Sunrise Sciences. Synthetic 
complete medium (SC) contained 1x Yeast Nitrogen Base (BD Biosciences/Difco) 
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without amino acids, synthetic drop-out medium supplement mix  or was purchased from 
Sigma. Cultures were started from by picking from freezer stocks into YPD and growing 
overnight, before transferring to new media for regrowth. Log phase cells were imaged 
and prepared for mass spec at an O.D. of approximately 2. Cells treated with 2% 2-
deoxyglucose (Sigma) were also log–phase cells at an O.D. of approximately 2. 
Stationary phase cells were grown a minimum of 48 hours before imaging or lysing for 
mass spec analysis.  All cultures were maintained shaking at 30°C.  
 Cells were imaged on a Nikon E800 fluorescence microscope with Photometrix 
Coolsnap CCD camera under oil immersion at 100x magnification. DIC images and 
fluorescent images in the GFP channels were collected using standard filter sets. Cell 
lysate was imaged on a Nikon TE2000-E with a Photometrics Cascade II camera at 60x 
magnification. Images were processed using Nikon Elements AR.  
 
Analysis of Gln1-GFP foci composition 
Methods for purification and mass spectrometry analysis of Gln1-GFP foci are listed in 
Chapter 3 in detail.  
 
Imaging flow cytometry for automating Gln1-GFP assays 
Methods for purification and mass spectrometry analysis of Gln1-GFP foci are listed in 
Chapter 3 in detail. In short, cells in early log phase (~2O.D./ml) were spun down and 
resuspended in SC with glucose concentrations ranging from 0 to 2% (again at 
~1O.D./ml). At 30 minute or 1 hour intervals, 300µl of culture was removed and fixed by 
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incubation with 4% formaldehyde at room temperature for 60 min, and washed with PBS 
before storing at 4°C. Cells were imaged on an Amnis ImageStream at 60x in brightfield 
and GFP channels. For all replicates, 50,000 cell images were at a flow rate of 40mm/s 
and a flow width of 7mm collected. Images were analyzed using custom templates in 
Amnis IDEAS 4.0 software. The percent of cells with foci was calculated as the number 
of cells with at least 30% of GFP fluorescence intensity in less than ~1µm2 . The percent 
penetrance data was graphed to produce onset curves which where fitted with an 
allosteric sigmoidal equation to calculate the onset rate of foci formation. The time value 
at fifty percent max penetrance was plotted against glucose concentration to determine 
energy dependence of puncta formation. 
2-deoxy glucose treatment 
Cells in late log phase (~OD 2) were treated with 2% 2-deoxyglucose (Sigma) for 2h 
shaking at 30C and imaged as described above. 
 
Author’s Contributions 
S. Pombe library re-analysis, TANGO score calculations, and abundance data analysis 
was the work of Mark Tsechansky. Glucose reduction experiment was the work of the 
author. 2-deoxy glucose experiments were the work of Mark Tsechansky and the author. 
 
SUPPORTING INFORMATION 
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Systematic Name 
 
Standard 
Name 
YAL003W EFB1 
YBL027W RPL19B 
YBL087C RPL23A 
YBL092W RPL32 
YDL136W RPL35B 
YDL191W RPL35A 
YDR064W RPS13 
YDR382W RPP2B 
YDR385W EFT2 
YER056C-A RPL34A 
YER074W RPS24A 
YER117W RPL23B 
YGL076C RPL7A 
YGR192C TDH3 
YIL052C RPL34B 
YIL069C RPS24B 
YJR070C LIA1 
YJR105W ADO1 
YJR123W RPS5 
YKL056C TMA19 
YKL117W SBA1 
YLR029C RPL15A 
YLR325C RPL38 
YML026C RPS18B 
YMR121C RPL15B 
YNL301C RPL18B 
YNL302C RPS19B 
YOL040C RPS15 
YOL121C RPS19A 
YOR133W EFT1 
YOR310C NOP58 
YOR317W FAA1 
YOR332W VMA4 
YPL131W RPL5 
YPL198W RPL7B 
Table S4.1. Yeast genes of the orthologs that became more insoluble in both yeast 
and worm with age.  
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Chapter 5: Discussion 
In the following sections discuss potential for widespread protein aggregation to 
influence cellular senescence, speculate on general models for how complex quaternary 
structures form in the first place, and why they may be inevitable, and future directions 
for research. 
General protein aggregation as a mechanism for senescence in quiescent cells  
Senescence is generally defined as the gradual decline in an organism’s ability 
carry out normal functions. Typically this correlates with increasing age. However, aging 
is not inherently linked to senescence, and lifespans can vary greatly between closely 
related species [183] and even within the same species [184], [185]. Moreover, the rate of 
deterioration is not necessarily linked with the rate of aging, but can be altered by genetic 
[186], chemical [131], and dietary interventions [181].  
 
To state these relationships thermodynamically, aging is the accumulation of 
entropy within cellular systems driving them towards equilibrium. However, organisms 
are not strictly subject to an inexorable increase in entropy as described by the second 
law of thermodynamics since they are not closed systems, but readily open to acquire free 
energy from and dump waste into their environments [187]. The question, “why then do 
organisms age?” still looms as a major question in biology.  
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 Protein aggregation may be one of the answers. While cells may by capable of 
acquiring free energy from their environment, they do not necessarily possess the means 
to use it to repair all types of damage. In the case of protein aggregates, degradation 
machinery is often incapable of overcoming the highly stable bonds formed [188]. 
Dividing cells, whether bacterial or of developing multi-cellular organisms, can simply 
divide away from the damage, diluting it at every cell division [189] or partitioning the 
damage into one of the two resulting cells, creating an old cell and a young cell 
[190][87]. Quiescent cells by definition lack this damage disposal mechanism, which 
may explain the higher incidence of protein aggregation diseases in quiescent cells (e.g., 
nerve and lens cells) [91], [191]. Furthermore, the mechanisms to control proteostasis 
decline with cellular age, reducing cell ability to prevent [153]and remove aggregates 
[123][192]. General protein aggregation increases the onset toxicity of disease causing 
protein aggregates. Thus an age dependent increase in general aggregation in quiescent 
cells could contribute to senescence and cell death. 
Of the few organisms that show negligible senescence, i.e. no apparent age-
related decline, many continue to grow for their entire lifetimes [193]. Thus continued 
cell division may be a requisite mechanism for escaping senescence from protein 
aggregation.  
 
 
This chapter has, in part, been excised and reworked from a review by O’Connell 
et al. 2012 [107]. 
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A case study in ambiguity: Are CTP synthase fibers cytoskeletal elements or 
bacterial sickle cell disease? 
The evolutionary conservation of CTP synthase filaments suggests that filament assembly 
of CTP synthase may provide a biologically useful purpose for cells, such as enhancing 
enzymatic regulation or improving CTP synthesis efficiency via compartmentalization, or 
even forming new cytoskeletal elements. This hypothesis may be (weakly) supported by 
the observation that yeast CTP synthase isozymes Ura7p and Ura8p co-localize to the 
same filaments [41]. However, enzymatic activity has yet to be shown for such filaments. 
Direct functional evidence for CTP synthase filaments is currently limited to the 
observation that CTP synthase helps determine the C. crescentus cell curvature, as well 
as to the observations that the assembly and characteristics of CTP synthase filaments 
seem to vary according to cell cycle or nutrient availability. However, as other model 
organisms in which CTP synthase filaments are found do not exhibit curved cell 
structures, the roles of filaments in those organisms are unresolved. Notably, filament 
formation and enzymatic roles are at least partially separable—Ingerson-Mahar et al. 
separated the filament-forming properties of CTP synthase from its enzymatic activity by 
showing that catalytically inactive synthetase domain mutants retained the ability to form 
filaments in C. crescentus [44].  
Another protein oligomerization event known to disrupt cell shape is interesting to 
consider in this context—that of sickle cell hemoglobin (HbS), arising from normal 
hemoglobin via a single glutamatic acid to valine substitution. Upon deoxygenation, HbS 
tetramers polymerize into rigid fibers capable of distorting red blood cells, impeding their 
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passage through capillaries. The structure and assembly of deoxy-HbS fibers have been 
studied extensively by electron microscopy [194–196]. Although individuals with sickle 
cell disease may have drastically reduced quality of life, the mutated gene has been 
proven to offer resistance against malaria [197], a life-saving advantage which may 
explain its prevalence in the population. Deoxy-HbS fibers thus represent a case of 
pathological aggregation that nonetheless offer a non-obvious yet substantial advantage 
to individuals carrying the mutation. Hence, it is worth noting that CTP synthase fibers 
might in fact be generally detrimental, yet have persisted throughout different phyla due 
to a similar yet undiscovered benefit to the organisms. CTP synthase and sickle cell 
hemoglobin illustrate the difficulties in distinguishing functional roles from aggregation 
when studying intracellular fibers. 
 
Are metabolic enzymes intrinsically more likely to self-assemble? 
As with the large-scale screens of protein localization, microscopy screens have also 
identified numerous new yeast prions [198]. Thus, whether assembling bodies for 
functional reasons, perhaps in response to metabolic cues, or simply aggregating 
pathologically, a much larger set of proteins than broadly appreciated may assemble into 
bodies or aggregate in vivo, perhaps whenever their abundances exceed tolerated limits 
[106]. The breadth of these phenomena raises the interesting possibility that perhaps all 
ordered proteins exhibit some level of self-aggregation or self-assembly. Because 
metabolic enzymes often exhibit complex quaternary structures and intersubunit allostery 
for the purpose of regulation, such quaternary structures might be intrinsically be more 
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susceptible to forming intracellular foci and fibers, simply as a result of a symmetrical 
arrangement of enzymes, replicating any favorable intersubunit interactions around the 
structure’s axes of symmetry. For example, stacked E. coli glutamine synthase 
dodecamers (dimers of hexamers) present six identical interfaces, one between each pair 
of the six repeated monomers around the dodecamer-dodecamer interface. Any favorable 
interaction at one such interface is therefore copied six times around the rings, making—
via avidity—for a potentially very strong overall interface. Such a mechanism of fiber 
formation is therefore intrinsically more likely for proteins with complex quaternary 
structures typical of those found among metabolic enzymes. Figure 1, below, shows a 
gallery of metabolic enzyme quaternary structures and fibers thought to be formed by 
such stacking mechanisms.  
 
 
Figure 5-1. A sampling of metabolic enzymes that self-assemble into fibers. 
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The quaternary structure of each enzyme is illustrated schematically (top row),  following 
90 degree rotation (middle row), and as visualized by electrion microscopy (bottom row). 
From left to right, the protein fibers are: rat liver acetyl-CoA carboxylase [199], oat ß-
glucosidase [31], E. coli glutamine synthetase [32], cow liver glutamate dehydrogenase 
[34], Drosophila CTP synthase (Liu 2010), human type II inosine monophosphate 
dehydrogenase [44], and human sickle cell mutant hemoglobin [200]. Crystal structures 
left to right are: S. coelicolor acetyl-CoA carboxylase ß-subunit, PDB ID: 1XO6 [201]; 
wheat ß-glucosidase, PDB ID: 2DGA [202]; E. coli glutamine synthetase, PDB ID: 1FY 
(Gill & Eisenberg 2001); Clostridium symbiosum glutamate dehydrogenase, PDB ID: 
1BGV [204]; human CTP synthase 2 PDB ID: 3IHL (Moche et al. Unublished data); 
human type II inosine monophosphate dehydrogenase, PDB ID: 1NF7 (Risal et al. 
Unpublished data); and human sickle cell hemoglobin, PDB ID: 2HBS [205]. All images 
created with Jmol.  
 
Given that metabolic enzymes are also often highly expressed and prone to allosteric 
regulation of alternate conformations, they would seem especially likely cellular 
candidates for self-assembly into higher order structures. The resulting fibers might 
provide regulatory functionality—e.g. providing fine tuning of enzymatic output by 
integrating allosteric interactions across the polymeric interfaces. Such appears to be the 
case for glutamine synthase, at least on the scale of binding of two homo-pentameric or 
hexameric rings [80]. Such fibers or assemblies might also provide stability or rigidity, 
especially as regards the formation of metabolic enzymes into more extensive structures 
such as crystals, which we might expect to serve as “self-chaperoning” structures, 
decreasing the likelihood for component proteins to unfold and form aggregates. Indeed, 
lens crystallins are frequently derived from metabolic enzymes [191]. Similarly, the 
crystalline cores of peroxisomes, or mitochondrial glutamate dehydrogenase fibers, are 
cases where homo-oligomeric enzymes are highly concentrated in stressful environments. 
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Protein aggregation as an evolutionary compromise 
 As we have discussed, the formation of intracellular protein aggregates is 
widespread and frequently functional. Therefore, this would seem to be a phenomenon 
that is not highly selected against, and that may actually be beneficial. However, 
phylogenetic analyses of multiple proteins suggest that a negative correlation exists 
between the rate of sequence change and the level of expression [169], [206], which has 
been interpreted to mean that mistranslation of a highly expressed protein is more likely 
to lead to dysfunctional aggregation than the mistranslation of scarcer proteins. Thus, 
despite the widespread existence of protein aggregates, the entire proteome is constantly 
under selection to avoid aggregates. The resolution of this conundrum would seem to be 
that aggregates are largely unavoidable and that functional organization around 
aggregates is an evolutionary compromise.  
 This begs the question of why aggregates are unavoidable given that evolutionary 
optimization often grinds genotypes and phenotypes to a very fine degree. The answer 
must lie in the realm of physical principles that not even evolution can refine, and as 
inferred above, sickle cell hemoglobin remains one of the most illustrative examples. A 
single mutation that occurred independently several times within a relatively short span 
of evolutionary time [207] leads to polymer formation, which can have the beneficial 
consequence of increased tolerance to malarial infection. We would argue that such 
mutations are largely unavoidable, especially in oligomeric proteins that by definition 
have the opportunity to form multiple, geometrically repeated contact points.  
 192 
Because oligomers are often allosterically regulated, and thus by definition assume 
multiple conformations, there may be unique opportunities for the formation of new 
mutational contact points. In many cases, new aggregates will be deleterious, as with 
Alzheimer's and other prion-based diseases, and the sequence of the protein will 
eventually be constrained by evolution in a concentration-dependent manner. In some 
cases, the aggregates will be neutral, and quaternary structures will form that have the 
opportunity to eventually benefit the cell—possibly through the adoption of a new 
regulatory functionality, as in the case of acetyl-coA carboxylase. CTP synthase remains 
a tantalizing example of a higher-order structure whose purpose either remains 
undiscovered, or that is truly near neutrality, and exists solely as a decoration in the cell. 
 
Future work 
Finally an exciting extension of the work described in this dissertation would be 
an expanded investigation for conservation of protein aggregation with age to more 
evolutionarily distant organisms.  Assaying in organisms that show negligible senescence 
would be particularly fascinating. These organisms would be excellent model systems to 
test if the rate of protein aggregate accumulation varies in proportion to lifespan and how 
protein aggregates are partitioned to prevent accumulation. 
Additionally, Characterization of foci forming proteins would also be valuable. 
Repeating the colocalization tests for known cellular structures on the 178 untested 
proteins would be quite informative. subdifraction localization of proteins in foci would 
likewise, be illuminating. Finally, checking the effects of the GFPS35T tag used in the 
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GFP library on the solubility partitioning would establish the implied link between foci 
formation and an observed shifts the insoluble phase, that we frequently see correlated. 
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